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Hematopoiesis is a tightly regulated process maintained by a small pool of 
hematopoietic stem cells (HSCs). Precise lifelong regulation of HSCs is important 
for self-renewal and differentiation into mature blood cells. Stra13/Sharp2/DEC1, 
a basic helix-loop-helix orange (bHLH-O) transcription factor plays important 
roles in cellular proliferation, differentiation and apoptosis. Previous studies have 
identified the importance of Stra13 function in maintaining homeostasis of T 
regulatory (Treg) cells as aged Stra13 knockout (KO) mice show defective T cell 
activation and exhibit a lymphoproliferative autoimmune disease. However, the 
role of Stra13 in hematopoiesis has not been studied so far. Our study 
demonstrates that Stra13 is highly expressed in early progenitors Lin- Sca1+c-Kit+ 
(LSK) cells and in the long term hematopoietic stem cells (LT-HSCs) /SLAM 
(CD150+CD48-) and its expression is downregulated in the differentiated 
progenitors. Moreover, Stra13 mRNA expression is elevated in the LSK 
progenitors in aged mice (22-24 months) compared with LSK fraction of young 
mice (2-3 months). Our analysis indicates that Stra13 is dispensable during steady 
state hematopoiesis. However, the LSK fraction of young Stra13 knockout mice is 
more sensitive to genotoxic stress. Moreover, aged Stra13 knockout mice show 
decreased percentages of SLAM+ and LSK fraction of the bone marrow and 
skewed progenitor levels. With the help of gene expression profiling studies, we 
have identified potential target genes that may potentiate the role of Stra13 in 
hematopoietic stem cell ageing and response to genotoxic stress. Our data 
uncovers a novel role of Stra13 in ageing and stress hematopoiesis. 
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1.1 Hematopoiesis and hematopoietic stem cells 
The human body produces billions of red blood cells, white blood cells and 
platelets every day to replace cells lost during cell turnover, injuries or trauma. 
Many homeostatic mechanisms within the body respond to stresses such as 
bleeding, infections or other toxic insults that allow the production of new blood 
cells and restore it to normal levels when the stress is resolved. This dynamic and 
highly orchestrated process of blood cell production and homeostasis is defined as 
hematopoiesis. It involves a tightly controlled expression of important 
transcription factors, growth factors and growth factor receptors. The sustained 
blood production of approximately 1011-1012 cells daily is the responsibility of 
very rare cells in the bone marrow i.e. the hematopoietic stem cells (HSCs) 
(Bryder et al., 2006; McCulloch and Till, 1960). HSCs reside at the top of the 
hematopoietic hierarchy and replenish all mature blood lineages through a 
cascade of differentiation steps. Primitive hematopoiesis originates in the yolk sac 
where the dominant function is the production of red blood cells (RBCs) to aid 
tissue oxygenation required for rapid embryo growth and development. Both the 
blood and endothelial cells arise from the hemangioblast of the yolk sac (Ema et 
al., 2006; Palis and Yoder, 2001). The next site of hematopoiesis is the aorta 
gonardo mesonephroses (AGM), which form the hemogenic endothelial cells 
(ECs) in the ventral and dorsal wall of the aorta that bud off HSCs. The placenta 
also harbors significant numbers of HSCs during this stage of embryo 
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development (Gekas et al., 2005). Subsequently definitive hematopoiesis occurs 
in the fetal liver, thymus, spleen and ultimately the bone marrow. In definitive 
hematopoiesis, long term HSCs (LT-HSCs) form short term HSCs (ST-HSCs). 
ST-HSCS give rise to multipotent progenitor cells (MPPs) that become restricted 
in their proliferation potential and differentiate to form progenitors of the 
myeloid, lymphoid or mixed lympho-myeloid lineage respectively which are 
Common Myeloid Progenitor (CMP), Common Lymphoid Progenitor or 
Lymphoid primed Multi Potent Progenitor (LMPP) (Adolfsson et al., 2005; 
Akashi et al., 2000; Kondo et al., 1997; Mansson et al., 2007). The myeloid 
progenitors commit further to form into granulocyte macrophage progenitors 
(GMP) arising from CMP or LMPP or into megakaryocyte/erythroid progenitors 
(MEP) that originate from CMP. These committed progenitors eventually 
differentiate into mature blood cells i.e. GMPs form committed precursors of 
eosinophils, macrophages, mast cells and neutrophils. CLPs are the source of 
committed precursors of B and T lymphocytes. Megakaryocyte Erythroid 
Progenitors (MEPs) differentiate to form RBCs and platelets. The differentiation 
of these committed progenitors into precursor cells and finally to mature blood 











Figure 1.1: Snapshot of hematopoiesis in the mouse and its hierarchical 
organization with the involvement different transcription factors during the 
differentiation cascade (Orkin and Zon, 2008). 
The upper panel [a] depicts the developmental time windows for different sites 
and stages of hematopoiesis in the mouse. Hematopoiesis originates in the yolk 
sac (YS) blood islands and soon after at the aorta-gonad mesonephros (AGM) 
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region, placenta, and fetal liver (FL). Hematopoiesis in each region leads to the 
production of specific blood lineages. The hierarchical organization and the 
transcription factors involved in hematopoiesis are depicted in the lower panel 
[b]. The red loops signify the stages at which the hematopoiesis is blocked due to 
deficiency of the given transcription factor. Transcription factors involved in 
oncogenesis are highlighted in red whereas those in black have not been found 
mutated or translocated in mouse/human hematological malignancies. 
 
1.2 Characteristics of hematopoietic stem cells 
To date, murine HSCs are one of the best studied and characterized stem cells and 
provide a model for other tissue specific stem cells. They were first discovered by 
Till and McCulloch more than 50 years ago where they found a clone of murine 
bone marrow cells capable of reconstituting all the lineages in an irradiated mouse 
host (Becker et al., 1963; Till and Mc, 1961). Murine HSCs express a wide 
variety of surface markers which allow easy identification and purification but 
also to simply characterize them in terms of their functional potential. A true HSC 
is a considered a rare cell type constituting 1 per 105 bone marrow cells (Harrison 
et al., 1988). The development of tools and selection methods based on cell 
surface markers has advanced the prospective identification and isolation of 
HSCs. During the course of differentiation, the changes in cell surface marker 
expression allow HSCs to be distinguished from its progenitors and differentiated 
cells. Many studies have demonstrated that murine HSCs are confined within a 
cell population that lacks the surface marker expression of mature blood cells 
(lineage markers). HSCs express a subset of markers- Stem Cell Antigen-1(Sca-1) 
and c-Kit and are termed as LSK population (Lineage-, Sca-1+ c-Kit+) (Okada et 
al., 1992; Spangrude et al., 1988). The LSK compartment is further subdivided 
into long term (LT) HSC which represents ~2% of LSK population, short-term 
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(ST) HSC and multipotent progenitors (MPPs) based on the expression of 
additional surface molecules such as CD34, Flt-3, Signaling lymphocyte 
activation molecule [SLAM (CD150,CD48)] and Endothelial protein C receptor 
(EPCR/CD201) (Balazs et al., 2006; Christensen and Weissman, 2001; Kiel et al., 
2005; Osawa et al., 1996). The SLAM family is a large group of cell surface 
glycoproteins in the immunoglobulin superfamily (Wang et al., 2001). From this 
superfamily, CD150 and CD48 have been used for the isolation and purification 
of enriched HSCs (Kiel et al., 2005; Yilmaz et al., 2006). Recently, along with 
CD150 and CD48 cell surface markers, CD229 and CD244 are other new markers 
of the SLAM family that are used for characterizing HSCs (Oguro et al., 2013). 
Studies on the SLAM family have shown that a simple combination of 
CD150+CD48- can give rise to a cell population that is specifically enriched in 
HSCs. One in five cells is capable of reconstituting a lethally irradiated mouse. 
The application of these markers complementing with other known HSC markers 
(Lin- CD150+CD48-Sca-1+c-Kit+) have paved the way for highly enriched and 
purer HSC population in which almost 50% of single cells can reconstitute 
lethally irradiated animals.  
HSCs are also characterized by their ability to efflux fluorescent DNA binding 
dyes such as Hoechst 33342 or Rhodamine 123 which is a mitochondrial activity 
marker. This led to the characterization of different flow cytometric profile of 
HSCs called the “side population” (SP) (Goodell et al., 1996; Li and Johnson, 
1992). The SP cells are capable of long term reconstitution potential express high 
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level of multidrug resistant pump, the ABC transporter Bcrp1/ABCG2, which 
mediates the efflux of the Hoechst dye (Zhou et al., 2001).  
1.3 In vitro and in vivo assays to detect HSCs 
A number of in vitro assays have been employed successfully to study the 
function of HSCs and progenitor cells. One of most commonly used assay is the 
colony forming cell (CFC) assay to quantify lineage committed progenitor cells. 
The cells are seeded on methylcellulose semi-solid media dishes containing a rich 
cocktail of cytokines and grown for 5-7 days. The colonies that arise from one 
single cell are analyzed based on morphology and scored by inverted light 
microscopy. Cobblestone area forming cell (CAFC) assay is a scaled down 
version of long term bone marrow culture setup in 96 well plates in the presence 
of a stromal cell layer. The primitive cells to be tested are seeded in situ on the 
stromal layer in a limiting dilution analysis. Each individual well is 
microscopically screened for the presence or absence of “cobblestone areas” 
which are defined as colonies of minimum five small non refractile cells that 
grow on the base the stromal layer at particular sequential time points after the 
assay has been initiated. The CAFC assay is not reliable as it can overestimate the 
number of hematopoietic cells and other methods are needed to validate its 
accuracy (Denning-Kendall et al., 2003). Another variant technique to detect 
more primitive human and mouse hematopoietic cells in vitro is the long term 
culture initiating cell (LTC-IC) assay (van Os et al., 2008). Similar to CAFC 
assay, the primitive cells are cultured on stromal layer for 4-5 weeks. The 
progenitors differentiate, die and disappear and the primitive cells which remain 
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in the culture are then reseeded on methylcellulose media and grown for 10-12 
days. The de novo CFCs that are formed from a LTC-IC are detected and scored. 
Colonies forming cells with high proliferative potential (HPP-CFC) are measured 
as dark colonies greater than 0.5mm and more than 50000 cells (McNiece et al., 
1990). This is generally used in detecting human HSCs. These in vitro assays 
allow a relatively easier and quicker method to estimate the frequency and 
function of stem or progenitor cells in a test cell population. It is particularly 
useful to determine the efficacy of certain drugs or compounds on HSC function. 
However the gold standard of studying HSC function is employing the in vivo 
transplantation assay which measures both self-renewal and differentiation 
potential of test cells after transfer to a myeloablated host. The competitive 
repopulation assay (CRA) is a relative measurement of the repopulation ability of 
the test cells compared to a reference standard of normal non fractionated bone 
marrow cells. Genetically marked test cells from the donor mice are transplanted 
into myeloablated mice along with a fixed number of competitor cells (Harrison et 
al., 1993; Szilvassy et al., 1990). The donors and hosts are chosen and 
distinguished based on the expression of hematopoietic cell marker CD45.1 or 
CD45.2 alloantigens which allow selective tracking of test cells and competitor 
cells in congenic mice. Competitor cells are syngenic to the recipient strain. For 
studying the function of human HSCs, xenogeneic immunodeficient nonobese 
diabetic- scid/scid (NOD/SCID) mice are used as recipients (Conneally et al., 
1997). However, it does not permit absolute or rigorous quantification of HSC 
frequency and number in the test cell population (Figure 1.3). Another variant, the 
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limiting dilution assay involves the titrating various doses of test cells against a 
fixed number of competitor cells (Harrison et al., 1993; Taswell, 1981). For each 
dose, the percentages of hosts which fail to engraft the test donor cells are 
determined. A best fit line is generated by Poisson statistics taking into account 
the positive and negative recipients from at atleast three different doses. The 
frequency of competitive repopulation units (CRUs) and the number of HSCs are 
then calculated. However, the most stringent measure of stemness is the serial 
transplantation assay (Lemischka et al., 1986). It may utilize any one of the above 
assays. First, the test cells are transplanted into primary recipients, allowed to 
engraft for two months followed by harvesting of the cells from primary 
recipients. They are then transplanted into secondary recipients and further from 










Figure 1.3: Schematics of Competitive Repopulation Transplantation Assay 
(Adapted from Bersenev 2011, Stem Cell Assays)  
a. The use of two different host strains for the donor (CD45.2) and competitor 
(CD45.1) mice allows tracking of the donor and the competitor population by 
flow cytometry. However, the host and competitor contribution toward 
reconstitution cannot be determined as they belong to the same congenic strain.  
b. By use of a heterozygous host strain CD45.1/CD45.2, reconstitution ability 
between the donor and the competitor can be ascertained accurately by flow 
cytometry. 
 
1.4 Regulation of hematopoietic stem cell homeostasis 
One of the most fundamental questions of biology is how stem cells are regulated. 
A large number of studies have shown that multiple factors are responsible for 
maintaining HSC renewal. Gene manipulation studies have identified important 
proteins, transcription factors, cell cycle regulators and epigenetic modifiers that 
intricately regulate HSC renewal (intrinsic factors). The microenvironment or 
HSC niche (extrinsic factor) and a complex network of interacting stimuli at 
various levels are invariably involved in the controlling self-renewal in HSCs. 





Figure 1.4a: Intrinsic and extrinsic mechanisms determining HSC regulation  
Intrinsic mechanisms are niche-independent and can alter or influence the 
epigenetic state of HSC since it is under the control of chromatin remodelers 
namely the transcription. Extrinsic mechanisms in HSC regulation are controlled 
by the environment, i.e. niche. A physical connection between the osteoblast and 
the HSC leads to the release of different growth factors that trigger different and 
parallel signal transduction pathways initiating the expression of downstream 
target genes (Rizo et al., 2006) 
 
1.4.1 Intrinsic regulation by key transcription factors 
A diverse range of transcription factors are involved in regulating hematopoiesis 
at different stages of the differentiation cascade. Many of the transcription factors 
identified are genes that are involved in chromosomal translocations in leukemia 
or are common integration sites in murine retroviral induced leukemia (Jude et al., 
2008). Some of them are essential during developmental process during the 




Runx1/AML1 (Runt related transcription factor 1) known to be disrupted by 
chromosomal translocation in leukemia produces a fusion protein that acts by a 
dominant interfering mechanism (Meyers and Hiebert, 1995). Conditional 
deletion of Runx1 in adult bone marrow results in expansion of HSCs and their 
progenitors by three fold (Growney et al., 2005; Ichikawa et al., 2008). Runx1 
deficient HSCs, similar to Myc deficient HSCs, show reduced repopulating ability 
in competitive and noncompetitive transplantation settings and with progressive 
loss of Runx1 deficient cells in the peripheral blood of transplanted recipients. 
Among the trithorax genes, the MLL (Mixed Lineage Leukemia) gene has been 
characterized extensively with respect to hematopoiesis. Gene disruption studies 
have identified the role of MLL in maintaining quiescence of HSCs (Jude et al., 
2007; McMahon et al., 2007). Acute deletion of MLL gene disrupts quiescence 
and allows entry of CD48- LSK (enriched in quiescent cells) to enter the G1 and 
shortly thereafter into the S phase leading to increased total number of LSKs. A 
recent study has highlighted a MLL transcriptional network that extends beyond 
its Hox targets, contains genes that are dependent and independent of the MLL 
cofactor, Menin. These genes include Prdm16, Mecom, Pbx1, Eya1, and Hoxa9 
involved in regulating HSCs. Prdm16 exhibits the highest activity and can rescue 
the intrinsic proliferation defect of MLL deficient HSCs (Artinger et al., 2013). 
Homeobox B4 (HoxB4), a member of the homeobox family of transcription 
factors was one of the first genes described to play a role in HSC fate 
determination. Overexpression of this gene results in strong expansion of HSCs 
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both in vitro and in vivo without the induction of leukemia in transplanted 
recipients (Antonchuk et al., 2002; Sauvageau et al., 1995). However, the loss of 
HoxB4 results in a mild defect in HSCs due to redundancy with other Hox 
proteins. Other members of Hoxa and Hoxb clusters (HoxA4, HoxA9 and 
HoxB6) similarly function to control adult HSC fate determination (Fischbach et 
al., 2005; Fournier et al., 2012; Lawrence et al., 2005; Thorsteinsdottir et al., 
2002).  
Gata2, a zinc finger transcription factor is important for definitive hematopoiesis. 
It is expressed before the emergence of HSCs and marks the hematopoietic 
specified cells (Minegishi et al., 1999). Gata2 function is essential for the 
generation of HSCs during the transition from endothelial to hematopoietic cell 
type and deletion of Gata2 in the Vec (vesicular endothelial cadherin) expressing 
endothelial cells leads to deficiency of LT-HSCs and intra-aortic cluster cells (de 
Pater et al., 2013). However, reduction of Gata2 expression or activity is essential 
for the commitment of HSCs (Minegishi et al., 2003).  Gata2 has an overlapping 
function with Runx1 in definitive hematopoiesis as double heterozygous mice of 
Gata2 and Runx1 do not survive and demonstrate hematopoietic defects at 
midgestation whereas the single heterozygous mice are viable with no overt 
phenotype (Wilson et al., 2010). Studies have also shown that Gata2 is important 
for maintaining quiescence of human HSCs as enforced expression of Gata2 leads 
to longer occupancy in the G0 phase of the cell cycle (Tipping et al., 2009).  
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Forkhead box O (FoxO) families of proteins participate in many physiologic 
processes, such as cell cycle arrest, stress resistance, differentiation, apoptosis and 
metabolism. Conditional knockouts of FoxO1, FoxO3 and FoxO4 in the 
hematopoietic system demonstrate reduction in the LT-HSCs and a functional 
decline in long term repopulation in both competitive and non competitive 
reconstitution assays (Tothova et al., 2007). FoxOs affect integrity of HSCs by 
regulating ROS levels. Germline loss of FoxO3a leads to increased levels of ROS 
in the LSK compartment which correlates with reduced levels of superoxide 
dismutase 2 (SOD2) and catalase expression and increased expression of p38 
MAPK in CD34- LSK cells. FoxO3a KO HSCs show defective maintenance of 
HSC quiescence and increased sensitivity to cell cycle specific myelotoxic injury. 
With ageing, there is a reduction in the HSC frequencies and therefore FoxO3a 
plays a critical role in the maintenance of HSC pool (Miyamoto et al., 2007). 
The polycomb protein Bmi-1 (B Lymphoma Mo-MLV Insertion Region 1) is 
involved in the maintenance of leukemic stem cells and HSCs (Iwama et al., 
2004; Lessard and Sauvageau, 2003; Ohta et al., 2002; Park et al., 2003). 
Embryonal development of HSCs is normal in Bmi-1 knockout mice. Adult   
Bmi-1 knockout mice display progressive reduction of HSCs, engraft poorly and 
exhaust prematurely in serial transplantation assays leading to postnatal 
pancytopenia. The loss of self-renewal in Bmi-1 knockouts is due to derepression 
of its target genes p16lnk4a and p19arf (Park et al., 2003).  
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Gfi-1(Growth factor independent 1), a zinc finger repressor restricts HSC 
proliferation, Gfi-1 knockout HSCs proliferate faster than their wild type 
counterparts and display a reduction in p21 expression but decreased HSC 
function in transplantation experiments (Hock et al., 2004; Zeng et al., 2004).  
Myc, a proto-oncogene first discovered in lymphoma and implicated in various 
cancers is also involved in HSC regulation. There is transient accumulation of 
HSCs in the absence of Myc in adult bone marrow. Perinatal deletion of Myc 
results in increase in of lineage negative, Sca-1 positive, c-kit negative cells 
displaying aberrant, senescent primitive progenitor phenotype (Baena et al., 
2007).  These Myc deficient HSCs are functionally defective and fail to engraft in 
both competitive and noncompetitive repopulation assays (Wilson et al., 2004). 
The Ets domain protein MEF/Elf4 (E74-Like Factor 4) maintains steady state 
HSC homeostasis and has also been implicated in leukemia. Elf4 knockouts 
exhibit increase in LT-HSCs (LSK, CD34-Flt3-) and shows a phenotype similar to 
c-Myc knockouts. El4 knockouts recover faster than wild type mice after 
myeloablation and outcompete in transplantation settings. However Elf4 knockout 
HSCs display reduced S/G2/M cells, reduced BrdU uptake and impaired cytokine 
stimulation in vitro but show normal bone marrow cellularity (Lacorazza et al., 
2006). 
Another important transcription factor for maintaining HSCs in the G0 phase of 
the cell cycle is the phosphatase and tension analog (PTEN). Disruption of 
PTEN increases the entry of HSCs into S phase and finally causes exhaustion of 
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the HSC stem pool. PTEN inhibits the phosphatidyl inositol-3 kinase/AKT 
pathway during cell cycle (Zhang et al., 2006). 
p53, the guardian of the genome has been to show to play critical roles in the 
maintenance of cell integrity under stress conditions by controlling its target 
genes which are involved in cell cycle arrest, DNA repair, apoptosis, senescence 
and metabolism. Hematopoiesis in p53 KO mice is almost normal during steady 
state hematopoiesis (Lotem and Sachs, 1993). p53 is preferentially expressed in 
the HSC compartment compared to the progenitor fractions such as CMP, GMP 
and MEP (Liu et al., 2009). Loss of p53 in HSC compartment leads to decreased 
HSC quiescence as monitored by reduction in CD34-LSK SP (side population) 
cells and increased proliferation of CD34-LSK cells. Through gene expression 
profiling studies, Gfi1 and Necdin were identified as p53 target genes important 
for maintaining HSC quiescence (Asai et al., 2012; Liu et al., 2009). HSCs 
lacking p53 reconstitute recipient bone marrow in a competitive repopulation 
assay during the first transplantation (TeKippe et al., 2003), but upon serial 
transplantation, p53 does not support the long term function of HSCs (Chen et al., 
2008). DNA damage by ROS results in upregulation of p53 in ROSlow HSCs 
because increased p53 levels decreases the ROS intracellular levels to protect the 
genome from ROS induced genomic damage. It does so by upregulating several 
antioxidant genes in ROSlow HSCs and therefore maintains quiescence for the 
survival of HSCs (Sablina et al., 2005). 
16 
 
1.4.2. Developmental regulators of HSCs 
The developmentally conserved pathways such as the wingless-type (Wnt), Sonic 
hedgehog (Shh), Notch and Fibroblast growth factor (FGF) have been known to 
play important functions during ontogeny but recently many studies have reported 
its role in regulating the adult hematopoietic stem cell compartment. They will be 
discussed in brief here to highlight their functions in HSC maintenance. 
Wnt/ β catenin pathway: The Wingless protein and its mouse homolog 
Integrase-1 comprise a family of 19 soluble secreted glycoproteins that are 
expressed by fetal and adult HSC environment (Staal and Luis, 2010). The 
canonical Wnt signaling pathway which involves the immature hematopoietic 
cells occurs in the BM stroma, where Wnt ligand binds to its receptor complex 
Frizzled (Frz) and two co-receptors Lrp 5/6 activating the transcription factor β-
catenin and its translocation to the nucleus brings about the activation of  cyclin 
D1 and c-Myc. Addition of soluble Wnt proteins like Wnt3a or Wnt5a in vitro 
enhances mouse and human HSC self-renewal, survival, and proliferation 
measured by engraftment into lethally irradiated recipient mice during 
transplantation assays (Austin et al., 1997; Murdoch et al., 2003; Willert et al., 
2003). In particular, the Bcl2 transgenic LSK cells expanded and maintained the 
immature phenotype after 7 days of ex vivo exposure to Wnt5a (Reya et al., 
2003). Overexpression of the constitutive form of β-catenin resulted in expansion 
of the HSC pool by up regulation of Notch1 and HoxB4 thus supporting the fact 
that the two pathways cooperate to maintain HSC homeostasis. Similarly ectopic 
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expression of constitutive β-catenin in lineage committed myeloid and lymphoid 
progenitors have conferred multilineage potential to these cells in vitro (Baba et 
al., 2006). However, the role of Wnt signaling in vivo is still unclear. Deletion of 
β-catenin or its homolog γ catenin has little effect on HSC renewal and 
reconstitution during transplantation assays using the Mx-Cre conditional systems 
(Jeannet et al., 2008; Koch et al., 2008). Vav-Cre conditional knockouts of β- 
catenin show defects in HSC renewal in transplantation settings but the frequency 
of LSK Flk2- and downstream progenitors are not changed. 
Hedgehog Pathway: The three secreted proteins of the hedgehog (Hh) family- 
the Sonic hedgehog (Shh), the Desert hedgehog (Dhh) and Indian hedgehog (Ihh) 
are major players in embryonic development. Hh ligand binds to its receptor 
Patched 1 (Ptch1) and releases a second surface protein Smoothened (Smo) 
allowing Smo mediated activation of two key Glioblastoma proteins Gli1 and  
Gli2 which act as positive activators of downstream target genes like Cyclin D1, 
Cyclin E, c-Myc and Vegf (Trowbridge et al., 2006). Shh has been shown to 
activate human CD34+ cells proliferation via bone morphogenic protein (BMP) 
signaling and Ihh expression on human stromal cells increases colony formation 
and engraftment function of human CD34+ progenitors (Bhardwaj et al., 2001; 
Kobune et al., 2004). However, contradictory findings from conditionally deleted 
Vav-Cre Smo knockout mice showed no global defects in lineage cell production 
but only impaired colony formation and reduced reconstitution in serial replating 
and serial transplantation assays respectively (Zhao et al., 2009). Interestingly, 
Gli-1 knockout mice show increased numbers of LSK CD34- cells and enhanced 
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reconstitution when compared to its wild type counterparts in vivo transplantation 
experiments (Merchant et al., 2010). Thus Gli-1 possesses antagonistic function in 
mediating Smo signaling for HSC renewal and maintenance (Warr et al., 2011). 
Likewise, using the Mx-Cre system, Smo deleted cells have no apparent 
phenotype during steady state hematopoiesis or upon 5-FU treatment thereby 
providing contradictory conclusions for the role of Hh in maintenance of HSC 
(Gao et al., 2009; Hofmann et al., 2009).   
Notch Pathway: The notch pathway genes consists of four notch members (1-4), 
which interact with 5 ligands, Jagged 1 and 2, and Delta 1,3 and 4. Upon binding 
to its ligand, the intracellular domain of notch (NICD) is cleaved by the γ 
secretase complex which then translocates to the nucleus and interacts with other 
coactivator proteins such as Core binding factor 1 (CBF-1) and Mastermind like 
(Maml) to bring about transcription of key target genes like Notch itself, Hey1, 
Hes1, and Hes5 (Bugeon et al., 2011; Schwanbeck et al., 2008; Weber and Calvi, 
2010). There is defective embryonic HSC development in Notch-1, Jagged-1 or 
CBF-1 knockout mice (Kumano et al., 2003; Robert-Moreno et al., 2005; Robert-
Moreno et al., 2008). The bone marrow niche, which consists of osteoblasts and 
endothelial cells, expresses Jagged and Delta ligands and contribute to signaling 
between the immature hematopoietic compartment and essential components of 
the BM niche leading to expansion of the wild type (WT) LSK cells but not Notch 
1/2 deficient LSK cells (Butler et al., 2010). Retroviral expression of activated 
Notch in Lin-Sca1+ cells leads to expansion of LSK cells population in-vivo 
through competitive transplantation assays while concurrently favoring 
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differentiation towards the lymphoid lineage and reduced differentiation towards 
the myeloid lineage (Stier et al., 2002). Conditional deletion of Jagged-1 or 
Notch-1 in the bone marrow compartment or stromal cells driven by Mx-Cre 
showed no apparent phenotype at steady state, transplantation and 5-FU treatment 
conditions (Mancini et al., 2005). Therefore, there is much debate on the role of 
Notch on HSC maintenance by limiting cell proliferation and differentiation due 
to redundancy and compensatory roles by other Notch ligands and their receptors 
but it maybe only important during certain stress conditions. 
TGF-β Pathway: The transforming growth factor (TGF) superfamily- TGF-β, 
activin and bone morphogenic protein (BMP) have diverse functions both during 
embryogenesis and in adult organisms. TGF-β type 1 receptor knockout mice do 
not have any hematopoietic defects during steady state as well as under stress 
conditions (Larsson et al., 2003). However, in vitro, TGF-β inhibits HSC 
proliferation and expansion and causes cell cycle arrest by the induction of cyclin 
dependent kinase inhibitors p21 and p57 (Cheng et al., 2000a; Cheng et al., 
2000b).  But in vivo deletion of Smad4 in HSCs results in decreased repopulation 
activity by transplantation into recipient mice demonstrating that Smad4 has a 
crucial role in regulation of HSCs (Karlsson et al., 2007). Ectopic expression of 
Smad7 in HSCs leads to disrupted Smad signaling and TGF-β responsiveness in 
vitro (Blank et al., 2006).  
FGF signalling: Murine HSCs express high levels of FGF receptors and their role 
in HSC fate regulation has been recently investigated. FGF-1 and FGF-2 when 
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added to cytokine and serum-free cultures have been reported to maintain/expand 
multilineage, serially transplantable, long-term repopulating HSCs of 
unfractionated mouse BM (de Haan et al., 2003; Yeoh et al., 2006). However, 
addition of standard cytokines to these in vitro cultures and stimulation of 
proliferation dominated FGF-dependent stem cell preservation. In addition, FGFs 
appear to have indirect effects as they can only support the maintenance of an 
undifferentiated state of purified murine HSC in culture when active stromal 
elements are present.  
1.4.3 Cell cycle regulation of HSCs 
The cell cycle machinery plays an important function maintaining the balance 
between proliferation and quiescence within HSCs to prevent the exhaustion of 
the stem cell pool. The four phases of the cell cycle G1 (gap 1), S (synthesis), G2 
(gap 2) and M (mitosis) are required for cell division and proliferation. Cells 
sometime temporarily stop dividing and exit the cell cycle through the G1 phase to 
become non dividing and quiescent. This state is referred to as the G0 phase. Upon 
certain external stimulation or cues, G0 cells re-enter the cell cycle for further 
proliferation. Positive regulators stimulate cell cycle progression by inhibiting cell 
cycle exit or by enhancing cell cycle reentry. Negative regulators slow down cell 
cycle progression by accelerating cell cycle exit and inhibiting cell cycle reentry 
(Wang et al., 2010). There is insufficient data to support if these regulators act at 
the G0/G1 transition or on the cell cycle directly. There is a distinct cell cycle 
activity in fetal, adult and aged HSCs. During fetal life, 95-100% of HSCs 
actively cycle in the fetal liver with a cell cycle transit time of 10-14 hours 
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(Bowie et al., 2006). In adulthood only 5% of the HSCs are actively cycling in the 
BM with 95% reaching quiescence by 4 weeks of age (Kiel et al., 2007). Once in 
the cell cycle, fetal and adult HSC transit at the same slow rates when compared 
to it more differentiated progenitors due to an extended passage through the G1 
phase of the cell cycle (Nygren et al., 2006).  HSCs occur in a hierarchical 
organization on the basis of quiescence with the most primitive stem cells existing 
in the G0 phase and possessing the highest stem cell activity. 5-bromo-2-
deoxyuridine (BrdU) labeling of dividing hematopoietic cells in vivo in normal 
adult mice has shown that 50% of all LT-HSCs divide every 6 days. At any given 
time, 75% of LT-HSCs are quiescent and after 57 days 99% of all LT-HSCs enter 
the cell cycle (Cheshier et al., 1999). Through label retention studies using BrdU 
and histone H2B-GFB, a highly dormant HSC (d-HSC) population within the Lin-
Sca1+cKit+CD150+CD48-CD34- have been identified that possesses stem cell 
activity validated by serial transplantation assays. These d-HSCs divide every 145 
days or five times per lifetime. But these d-HSCs are rapidly and efficiently 
activated by G-CSF stimulation or in case of BM injury. These activated HSCs 
return back to dormancy once the injury is repaired (Wilson et al., 2008). 
The function of cyclins, cyclin dependent kinases (CDKs) and members of the 
retinoblastoma (Rb) family have been well documented with respect to 
differential expression within the hematopoietic system (Passegue et al., 2005). In 
eukaryotic cells, the cyclin-CDK complexes drive the progression of cell cycle. 
The CDK inhibitors of the KIP family (p21, p27 and p57) inhibit CDK2 
complexes whereas those of INK family (p15, p16 and p18) inhibit CDK4/6. 
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Since the CDK4/6 complex is active at the G1/S boundary and the CDK2 
complex during the S phase, the loss of inhibition by CDK inhibitor differentially 
affects the cells especially at G0 phase (HSCs) when compared to rapidly cycling 
cells (progenitors). p21 knockout mice show increased HSC proliferation and 
increased absolute number of HSCs under homeostatic conditions. Premature 
death occurs in these knockouts on exposure of the animals to myelotoxic injury 
due to HSC depletion. The self-renewal of HSCs from these mice is impaired in 
serially transplanted bone marrow. Therefore, p21 acts as a molecular switch 
controlling the entry of HSCs into the cell cycle and its loss leads to increased cell 
cycling and stem cell exhaustion (Cheng et al., 2000b). Interestingly, deletion of 
p18, an early G1 phase inhibitor leads to increased number of HSCs with self-
renewal potential (Yuan et al., 2004). The loss of p18 is epistatic to p21 loss and 
the double mutant shows no stem cell exhaustion and HSCs proliferate better than 
p21 null HSCs (Yu et al., 2006a). In contrast, p27 knockouts exhibit normal HSC 
numbers and proliferation but outcompete wild type cells during transplantation. 
p57 is expressed predominantly in quiescent HSCs and conditional deletion of 
p57 in the hematopoietic compartment leads to loss of quiescence in HSCs in the 
G0 phase with severe defect in self-renewal capacity and reconstitution ability 
after transplantation. Double knockouts of p21 and p57 displayed a severe 
phenotype of HSC loss and knockin of p27 at the p57 locus rescued the defects of 
p57 deficient HSCs which suggests a functional overlap between p57 and either 
p21 or p27 (Matsumoto et al., 2011). It has also been reported that quiescence of 
HSCs by TGF-β and Thrombopoietin (THPO) is mediated by p57 upregulation 
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(Qian et al., 2007; Scandura et al., 2004). p16 is highly expressed in LT-HSCs 
and is a downstream target of Bmi-1 and plays a role in HSC senescence and is 
upregulated during ageing (Lessard and Sauvageau, 2003; Passegue et al., 2005). 
The HSCs of ageing p16 knockouts function better in functional assays 
suggesting p16 may negatively regulate HSC numbers during ageing (Janzen et 
al., 2006).  
1.4.4 Critical signaling molecules 
One of the first important growth factor-receptor interactions involved in 
hematopoiesis is stem cell factor (SCF) or steel factor (SF), a ligand for c-Kit, a 
transmembrane tyrosine kinase signaling molecule whose functions have been 
documented in late fetal and adult hematopoiesis. The dominant white spotting in 
mouse reported in the early 1900s was found to be encoded by c-Kit (Chabot et 
al., 1988; Geissler et al., 1988). The two different splice forms of c-Kit are 
transmembrane bound and the soluble form SCF. Stimulation of the 
transmembrane form lacking a proteolytic cleavage site leads to sustained 
activation of the c-Kit receptor whereas the soluble form brings about rapid and 
transient activation of the same receptor. The mechanistic and functional 
differences between the two isoforms suggest signaling differences where the 
membrane bound SCF leads to prolonged activation of Erk1/2 and p38 mitogen 
activated protein kinase (MAPK) in comparison to the soluble form. The 
spontaneous mouse mutant harboring the Sld allele and encoding the secreted SCF 
is involved in hematopoiesis only after bone marrow injury. The engineered mice 
that lacked the protease site showed delayed hematopoietic recovery and 
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increased mortality after sublethal radiation (Tajima et al., 1998). Sl mutants 
devoid of both forms of SCF exhibit reduced steady state hematopoiesis which 
demonstrated that only the membrane bound form is sufficient for maintaining 
HSC homeostasis. Signaling through the c-Kit receptor is essential for 
erythropoiesis, lymphopoiesis, megakaryopoiesis, melanogenesis, gametogenesis 
and melanogenesis in mice (Lyman and Jacobsen, 1998; Ronnstrand, 2004). c-Kit 
is highly expressed in HSCs where it acts as a survival factor and acts in synergy 
with other cytokines to augment HSC proliferation (de Sauvage et al., 1996). 
Studies have shown that c-Kit plays a redundant role in steady state hematopoiesis 
but functions as an important signaling molecule for HSC self-renewal and/or 
regulation of committed progenitors after transplantation. Humans with c-Kit 
deficiency do not have any hematopoietic defects which suggest its redundancy in 
function when compared to mouse hematopoiesis (Lyman and Jacobsen, 1998).  
Fetal liver kinase (Flk2 or Flt3) is a type III class receptor similar in biological 
functions to c-Kit in vitro. Flt-3 has a transmembrane ligand and the soluble form 
of the ligand is generated through alternative splicing (Christensen and 
Weissman, 2001). Recent studies have reported the surface expression of Flt3 is 
not observed in LT-HSCs and high expression of Flt3 is infact associated with 
loss of stem cell renewal (Adolfsson et al., 2001). The surface expression of Flt3 
is important in the LSK population which is actively cycling and provides short 
term multipotent engraftment activity. The Flt3- population is dominated by the 
quiescent LT-HSCs (Christensen and Weissman, 2001; Passegue et al., 2005). 
Flt3 may play a redundant role as Flt3 null mice have normal levels of HSC 
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(Sitnicka et al., 2002). The differentiation of dendritic cells and lymphocytes is 
also brought about by Flt3 signaling (Lyman and Jacobsen, 1998).  
Thrombopoietin (THPO) is a cytokine that was initially identified to maintain 
exclusive regulation of megakaryocytic and platelet production (de Sauvage et al., 
1996; Kaushansky, 2005). But over a period of years many groups have identified 
unique roles of THPO during developmental hematopoiesis and maintenance of 
HSCs (Ku et al., 1996; Petit-Cocault et al., 2007). Indirect studies have suggested 
that mice deficient in THPO or its receptor c-Mpl have reduced numbers and/or 
functions of HSCs (Fox et al., 2002; Kimura et al., 1998). THPO regulation of 
HSCs has also been implicated due to high expression of its receptor c-Mpl in 
HSCs and THPO responsiveness of highly purified HSCs (Solar et al., 1998).  
When present with other cytokines, THPO supports the expansion of colony 
forming units, competitive repopulation units and cell accumulation in vitro. For 
example, in the presence of THPO alone, the LSK cells proliferate very slowly or 
not at all but by the addition of another cytokine SCF, the clonal efficiency and 
cell accumulation increases in vitro as THPO functions by increasing the number 
of cells and reducing the time delay to enter the cell cycle (Ku et al., 1996; 
Sitnicka et al., 2002). However some reports also suggest that THPO is not 
effective in maintaining HSC potential under defined conditions in vitro (Uchida 
et al., 2003). Thus THPO has opposing functions on LT-HSC when compared to 
its differentiating progeny. Patients with loss of functional mutations in c-Mpl 
receptor and congenital amegakaryocytic thrombocytopenia (CAMT) exhibit a 
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multilineage deficiency and aplastic anaemia within 2 years of birth resembling a 
stem cell deficiency (Ballmaier et al., 2003). 
 
 
Figure 1.4.b: Summary of the extrinsic and intrinsic mechanisms of 
hematopoietic stem cell (HSC) regulation  
Convergence of signal transduction pathways and involvement of different 
transcription factors, developmental genes, epigenetic modifiers and critical 





1.5 The ageing hematopoietic stem cell compartment 
Stem cells are essential for maintaining homeostasis of mature functional tissues 
and organs. The unique ability of a stem cell is to self renew and replenish 
damaged and dying cells throughout an organ’s lifetime and hence stem cells are 
thought to be immortal and free from ageing. However, this is not true as there is 
an age specific functional decline of stem cells which leads to defective ability to 
repair tissues and increased susceptibility to cancer and other age related diseases. 
Gatekeeping tumor suppressor genes like p16lnk4a, p19Arf and p53 negatively 
regulate cellular proliferation and survival (Kinzler and Vogelstein, 1997; Signer 
and Morrison, 2013). They negatively regulate stem cell function ageing as their 
expression and function increases with age in multiple tissues (Janzen et al., 2006; 
Krishnamurthy et al., 2006; Krishnamurthy et al., 2004). In many stem cells, the 
expression of let-7 micro RNA increases with age. Let-7 upregulation inhibits the 
expression of high mobility group transcriptional regulator, Hmga2, a proto-
oncogene expressed in stem cells in old mice and a target of let-7 (Nishino et al., 
2008). This loss of function of Hmag2 in adult stem cells like neural stem cells 
increases the expression of p16lnk4a and p19Arf reducing the frequency and self 
renewal potential of the stem cells.  Ageing of the hematopoietic system not only 
causes tissue attrition but also increased incidence of many hematologic 
malignancies including myeloid and lymphoid leukemia (Henry et al., 2011). 
Ageing is accompanied by an overall reduction in hematopoietic competence 
despite the enormous proliferative and regenerative capacity of HSCs. 
Immunosenescence which refers to global changes or alterations that have an 
28 
 
effect on the immune system are among the factors associated with ageing. 
Increase in ageing and associated changes in the immune system predispose the 
elderly to infectious diseases, autoimmunity, vaccine failure, anemia and 
leukemia. Many reports have demonstrated that ageing of the innate and adaptive 
immune system originates at the top of the hematopoietic hierarchy i.e. 
dysfunction of HSCs. For example, B cell lymphopoiesis is impaired during 
ageing as there is a decreased regeneration of B cell precursors linked to defective 
function of aged HSCs (Kuranda et al., 2011; Miller and Allman, 2005). The old 
B cells produce antibodies with less affinity and diversity. In contrast, there is an 
increase in the numbers of myeloid precursors in the myeloid compartment but 
there is a decrease in phagocytic ability and oxidative burst in neutrophils and 
macrophages (Plowden et al., 2004). 
1.5.1 Phenotype of aged HSCs 
1.5.1.1 Increased HSC frequency and numbers but reduced regenerative 
potential 
HSCs have been defined by a specific set of cell surface markers in both mice and 
humans. With ageing, the numbers of these defined HSCs increase two to ten fold 
in humans and mice (Table I). However, under stress conditions and regeneration 
(serial transplantation assays), these aged HSCs are impaired in function and 
demonstrate reduced regenerative potential. The increase in HSC numbers cannot 
compensate for the loss of function and as a result it leads to diminished 
regenerative capacity of the aged HSC pool (Sudo et al., 2000). The increase in 
HSC numbers has been proposed to be a compensatory mechanism during ageing 
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to overcome its decreased regenerative function. Other mechanisms propose 
symmetric cell divisions for increased frequency of aged HSCs and impaired 
function. Similarly, age specific changes in expression, response to extrinsic cues 
and secretion of niche factors may also contribute to increased HSC numbers 
(Mercier et al., 2012; Wagner et al., 2008). 
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Table I. Ageing associated changes in mouse HSCs [Adapted from (Geiger et 
al., 2013)]. 
 
1.5.1.2 Skewed differentiation potential 
The most distinct hallmark of an ageing hematopoietic system is the expansion of 
the myeloid compartment. Other features include anaemia and decreased fitness 
of the adaptive immune system. There is skewing of hematopoietic stem cell 
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differentiation with increased outputs of the myeloid lineage but compromised 
quality of myeloid cells and decreased output of the lymphoid and erythroid 
lineage when compared to young HSCs (Beerman et al., 2010). Lineage 
specification in aged HSCs is also disrupted with decreased numbers of CLP cells 
and increased numbers of CMP cells in comparison with young mice (Rossi et al., 
2005). This skewing effect from early lymphoid to myeloid lineage may be 
caused by changes in HSC differentiation and the proliferative ability and survival 
of CMP. Another explanation is the functional heterogeneity of the long term 
HSCs in terms of differentiation potential, some HSCs have low tendency to 
differentiate into lymphoid cells and consequently are myeloid biased. Some 
HSCs show a reverse trend and hence are lymphoid biased whereas others are 
balanced HSCs with a balanced equal output of myeloid and lymphoid cells (Benz 
et al., 2012; Dykstra et al., 2007; Muller-Sieburg et al., 2002). Few reports 
suggest that the composition of the HSC pool changes with ageing with no 
alterations in its differentiation potential. The number of myeloid biased HSC 
clones increases in comparison with lymphoid biased or balanced clones upon 
ageing (Morita et al., 2010; Muller-Sieburg et al., 2004). As a consequence all 
HSC subtypes age by a combination cell intrinsic and extrinsic mechanisms that 
result in lineage skewing. 
1.5.1.3 Differences in homing and mobilization to and from the bone marrow 
The HSC niche plays an important role in maintaining HSC quiescence, self 
renewal, differentiation and mobilization. Young HSCs home to the bone marrow 
and restrict themselves in close proximity to the endosteum whereas aged HSCs 
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localize themselves away from the endosteal stem cell niche after transplantation 
(Kohler et al., 2009). Mobilization, a phenomenon for recruitment of HSCs to the 
peripheral blood through the use of stimulatory signals like cytokines and 
chemotherapy is also enhanced in aged HSC when compared to young HSCs 
(Geiger et al., 2007; Liang et al., 2005; Xing et al., 2006). These data demonstrate 
the differences in the adhesive properties of aged HSCs and their interaction with 
the niche cells in the aged bone marrow. However, a better understanding of the 
crosstalk between aged HSCs and the niche cells and the expression of adhesion 
molecules in vivo is still lacking due to difficulties in experimentally determining 
the complex interactions in vivo. 
1.6 Mechanisms involved in HSC ageing 
1.6.1 Cell intrinsic mechanisms 
Genome wide expression studies comparing the HSCs from young and aged mice 
may not only identify novel biomarkers of stem cell ageing but also provide 
useful mechanisms of ageing in HSCs and other stem cells. Transcriptome 
profiling between young and aged HSCs have identified a general downregulation 
of lymphoid genes and an upregulation of myeloid genes in aged HSCs. For 
example; the expression of Runx1 is upregulated in aged HSCs and one of the 
factors responsible for skewing of HSCs towards the myeloid lineage (Rossi et al., 
2005). Furthermore, genes associated with proinflammatory state like nuclear 
factor κB (NF-κB), Interleukin 6 (IL-6), Tumor Necrosis Factor alpha (TNF-α) 
and Interleukin 1β (IL1-β) are also upregulated in aged HSCs along with 
molecules involved in cell to cell interactions such as P selectin and intercellular 
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adhesion molecule 1(ICAM-1) (Franceschi et al., 2000) (Figure1.6a). 
Consistently, expression of genes related with protein folding like heat shock 
protein 8 (hspa8) and HSP40 are highly expressed in aged HSCs which shows 
that protein integrity maybe deregulated in aged HSCs similar to increase protein 
damage and misfolding in aged fibroblasts (Baraibar and Friguet, 2013). 
1.6.1.1 Oxidative damage, mitochondrial DNA mutations and metabolism 
Oxidative damage, which is primarily carried out by the production of reactive 
oxygen species (ROS) causes a decline in mitochondrial function by affecting 
mitochondrial DNA (mtDNA) replication and transcription. A feedback loop is 
created which results in increased ROS production and a cumulative damage to 
the mitochondria which leads to telomere attrition and replicative senescence and 
ageing as observed in differentiated fibroblasts. Transgenic mice with increased 
mtDNA mutations due to deficiency of mtDNA polymerase catalytic subunit 
gamma (POLG) develop anemia and lymphopenia, which demonstrates that 
mtDNA damage, mutations, ROS and hematopoiesis are coupled. HSCs with 
elevated ROS production demonstrate increased activation of mammalian target 
of rapamycin (mTOR) and p38 mitogen activated protein kinase (MAPK) that 
leads to exhaustion of HSCs during serial transplantation assays in vivo (Jang and 
Sharkis, 2007). Similarly, mice lacking the Forkhead box O (FOXO) family of 
transcription factors have higher production of ROS in HSCs when compared to 
wild type control mice with short term HSC hyper proliferation but increased 
HSC apoptosis (Miyamoto et al., 2007; Tothova et al., 2007). Contrary to this, 
there have been reports that suggest that the levels of ROS production and levels 
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are not elevated in physiologically aged HSCs when compared to POLG knockout 
mice. mtDNA mutations may not directly impact HSC function although 
mitochondrial function maybe required for multilineage stem cell differentiation 
(Norddahl et al., 2011). This warrants further study to directly link mtDNA 
mutations and oxidative stress with HSC ageing (Figure 1.6a). 
1.6.1.2 Loss of cell polarity and connection with CDC42 
Aged HSCs have changes in cell adhesion molecule expression and therefore are 
linked with changes in cell polarity. Gene expression studies have shown that 
there is increased expression of Cell division cycle 42 (CDC42), a small RHO 
GTPase cell division control protein. It is known to be expressed in mononuclear 
hematopoietic cells and has been strongly associated with ageing and morbidity in 
humans (Kerber et al., 2009). CDC42 is turned on to a GTP bound state from a 
GDP bound state in the presence of various HSC stimuli like growth factors, 
cytokines, extracellular matrix (ECM) proteins etc. Recent data suggests that as 
HSC age there is substantial increase in the expression of CDC42 which causes 
disruption of cell polarity in aged HSCs and random distribution of tubulin, other 
planar cell polarity markers and indiscriminate nuclear distribution of acetylated 
H4K16 (epigenetic polarity) (Florian et al., 2012) (Figure 1.6a). 
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1.6.1.3 DNA damage and telomere attrition  
Cells are confronted with multiple insults to their DNA every day. As discussed 
earlier, ROS a metabolic and natural by product can cause oxidative damage in 
cells. Other forms of DNA damaging agents include ultra violet radiation and the 
natural error rate upon DNA replication. Moreover, thousands of lesions arise in 
the genome of each cell on a daily basis due to constant depurination and 
hydrolysis of DNA (Lindahl, 1993). Thus the DNA repair machinery plays an 
enormous importance in ensuring that the integrity of the DNA content is intact 
and free from errors. Therefore, it is imperative that HSCs are equipped with 
robust repair mechanisms and response to prevent its progeny from inheriting 
error prone genomic alterations. As majority of HSCs reside in G0 phase of the 
cell cycle they are less prone to replication errors (Cheshier et al., 1999). In 
addition, HSCs produce low levels of ROS compared to its progenitors and are 
capable of fluxing out toxic compounds (Goodell et al., 1996; Tothova et al., 
2007). HSCs are resistant to irradiation and formation of double strand breaks 
whereas the myeloid progenitors undergo apoptotic cell death (Mohrin et al., 
2010). As HSCs are quiescent, they employ an error prone repair mechanism or 
non homologous end joining whereas the progenitors use the high fidelity 
homologous recombination (HR) repair pathway. Thus HSCs are somewhat 
protected from DNA damage as they are quiescent but utilize a suboptimal and 
error prone DNA repair pathway which presents a scenario of DNA damage 
accumulation during ageing. Many studies have reported that it is the 
accumulation of DNA lesions and mutation which are responsible for age related 
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phenotypes in different stem cells (Park and Gerson, 2005). In this regard, HSCs 
are in no way different from other stem cells. Both mouse and human HSCs 
harbor increased levels of DNA damage highlighted with increased H2AX foci 
formation in the nucleus indicative of double stranded breaks (Rossi et al., 2007b; 
Rube et al., 2011; Yahata et al., 2011). Several transgenic mice show defective 
HSC function and DNA maintenance. Transplantation of HSCs with 
compromised DNA integrity has shown an age related decline in HSC function 
leading to reduced self renewal, repopulation capacity and increased apoptosis 
(Navarro et al., 2006; Nijnik et al., 2007).  DNA damage trigger various signaling 
molecules leading to various cell cycle check point activation, apoptosis and 
differentiation. Major molecules include the tumor suppressor p53, cyclin 
dependent kinase inhibitor 2A (CDKN2A or p16INK4A), anti apoptotic members of 
the family BCL2 and B cell activating transcription factor (BATF) which 
enhances lymphoid differentiation of HSCs in response to gamma radiation 
(Mandal and Rossi, 2012; Wang et al., 2012a). The importance of p53 in HSC 
ageing is still controversial.  On the other hand p16INK4A expression is high in 
aged HSCs and its absence in aged HSCs modestly rescues the compromised 
numbers and defective self renewal capacities during transplantation settings. 
Other studies have reported no role of p16INK4A during ageing of HSCs under 
steady sate conditions (Attema et al., 2009). Only a handful of genes are 
differentially expressed in young and aged HSCs function in DNA repair and 
stress response, some of which include genes like Bloom syndrome protein (Blm), 
XPA binding protein 2 (Xab2) and X ray repair cross completing protein 1 
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(Xrcc1). Contrary, knockouts of mice for xeroderma pigmentosum group D 
complementing protein (Xpd) and mRNA transport regulator 3 (Mtr3) do not 
exhibit any function HSC defects during ageing under steady homeostatic 
conditions (Rossi et al., 2007a).  These observations reinforce that the decreased 
regenerative potential of aged HSCs results not only from accumulating DNA 
damage during ageing but is also linked to telomere shortening.  
Telomeres are regions of repetitive DNA sequences that characterize the ends of 
chromosomes and prevent DNA damage response and DNA repair pathway 
activation. Telomeres are maintained by the enzyme telomerase that prevents 
them from shortening after each round of DNA replication. Shortening of 
telomeres gives rise to unprotected ends of chromosomes which are recognized as 
chromosome breaks or DNA damage. Telomeres in humans shorten with age. In 
murine studies, telomere shortening occurs in HSCs during serial transplantation 
assays and HSCs which lack telomerase have reduced serial transplantation 
potential (Allsopp et al., 2003b). In addition, third generation of mice lacking 
telomerase enzyme show premature ageing of HSCs as well as other type of stem 
cells (Choudhury et al., 2007). Murine HSCs express low levels of telomerase and 
ectopic expression of telomerase maintains telomere length but does not increase 
the self renewal capacities of HSCs in transplantation assays (Allsopp et al., 
2003a). Mice with telomere dysfunction display impaired mitochondrial 
biogenesis and function, decreased gluconeogenesis and increased productions of 
ROS levels as discussed earlier. Treatment with antioxidant does not rescue the 
transplantation defects of telomere disrupted HSCs (Sahin et al., 2011). 
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1.6.1.4 Epigenetic regulation during ageing 
The role of epigenetic stability in stem cell ageing has recently come into 
highlight. The transmission of epigenetic information to daughter cells ensures 
proper self renewal and function of HSCs. Epigenetic marks that maintain HSC 
decline and become altered with ageing with changes in DNA methylation 
signatures due to failure of DNA methyltransferases, histone methyl transferases 
and acetyl transferases to copy HSC specific DNA and histone modification to 
daughter strands (Beerman et al., 2013; Bocker et al., 2011; Rando and Chang, 
2012). Downregulation of genes involved in chromatin remodeling and chromatin 
dependent transcriptional silencing are observed in aged HSCs. These genes 
include SWI/SNF complex such as Smarca4 (SWI/SNF-related matrix-associated 
actin-dependent regulator of chromatin subfamily A member 4), Smarcb1, histone 
deacetylase 1 (Hdac1), Hdac2 and Hdac6. Other genes like sirtuin 2 (Sirt2), Sirt3, 
and Sirt7 are also downregulated upon ageing in HSCs (Chambers et al., 2007). 
Similarly the level of acetylation of histone H4 on lysine 16 (H4K16) is reduced 
in aged HSCs and may be one of the important factors contributing to the ageing 
process (Florian et al., 2012). Epigenetic modifications by the polycomb group of 
proteins are best studied during blood development. The combined functions of 
polycomb repressive complexes PRC1 and PRC2 are involved in replication of 
histone modifications and bring about chromatin compaction and gene repression. 
Polycomb mediated gene repression is through the formations of H3K27me3 
(trimethylated H3K27) by histone methyltransferase enhancer of zeste homolog 2 
(EZH2). The chromobox protein homolog (CBX) in BMI-1 containing PRC1 
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recognizes this H3K27me3. Aberrant expression of BMI1, MEL18, RING1, 
EZH2 and other members of PRC1 and PRC2 complex are involved in 
deregulated function of blood formation in mice (Klauke and de Haan, 2011). Of 
these genes, Bmi-1 is important as it binds to genomic regions marked by 
H3K27me3 (repressive) and H3K4me3 (active) in the hematopoietic progenitors 
which indicate that these genes are transcriptionally inclined to be expressed 
during differentiation (Bernstein et al., 2006; Oguro et al., 2010). Deregulation of 
Bmi-1 gene results in the aberrant expression of the splice variants of the INK4a 
locus p16INK4a and p19Arf that inhibit cell proliferation and cause apoptosis. 
Coincidently, derepression of B cell lineage genes have been reported in Bmi-1 
knockout HSCs which leads to reduction of H3K27me3 and increase in B cell 
generation and thus Bmi-1 has been considered as one of the genes regulating 
lineage specification in HSCs during ageing (Pollina and Brunet, 2011). With the 
exception of H4K16 acetylation and DNA methylation large scale screening, 
there is limited data on the genome wide analysis of other epigenetic modification 
in young and aged HSCs. If epigenetic changes have a key role in ageing of 
HSCs, intervention of pharmacologic drugs that alter epigenetic modification 
could be used therapeutically to reverse the effects of HSC ageing such as 
valproic acid and decitabine which are already in clinical use (Pollina and Brunet, 
2011; Rando and Chang, 2012).  
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1.6.1.5 Switch from canonical to non canonical Wnt signaling 
Expression of multiple members of Wnt signaling in both hematopoietic cells as 
well as in non-hematopoietic stromal cells has been documented (Malhotra and 
Kincade, 2009). The canonical Wnt protein Wnt3a and the non canonical Wnt 
protein Wnt5a have been reported to play important roles in hematopoiesis (Luis 
et al., 2011; Nemeth et al., 2007). There is an increase in the expression of Wnt5a 
in middle aged (10 months) and aged (20-24 months) LT-HSCs and Lin- cells 
from C57BL/6 and DBA/2 mice but absent in young (2-3 months) LT-HSCs 
(Florian et al., 2013). Aged LT-HSCs present lower levels of β-catenin and are 
cytoplasmic in localization when compared to young LT-HSCs which are 
predominantly nuclear. Reduced transcript levels Axin2, a downstream target of 
canonical Wnt pathway was reported in aged LT-HSCs (Brack et al., 2007). 
Young LT-HSCs treated with Wnt5a causes ageing associated stem cell apolarity, 
features of ageing myeloid-lymphoid differentiation skewing through the 
activation of Rho GTPase Cdc42 and reduction in regenerative potential. This 
shift from canonical to non canonical Wnt signaling during the ageing of LT-
HSCs initiated by Wnt5a is cell intrinsic but how the expression of Wnt5a in 






Figure 1.6a: Cell intrinsic mechanism of HSC ageing 
Young HSCs generally produce low ROS and establish cell polarity by Cdc42. 
Along with telomere maintenance, a robust DNA repair machinery exists in 
young HSCs. Aged HSCs have higher Cdc42 activity which causes loss of 
H4K16ac in the nucleus depolarization of planar cell polarity markers in the 
cytoplasm. Higher ROS production, telomere shortening and high DNA damage 
lead to activation of p16, BCl2, VATF and p53 leading to senescence, apoptosis 
or differentiation. Changes in epigenetic marks such as H4K16ac lead to reduced 
genome wide level of acetylation upon ageing [(Geiger et al., 2013); Nat Rev 





1.6.2 Cell extrinsic mechanisms 
1.6.2.1 The importance of the niche in HSC ageing 
The hematopoietic stem cell (HSC) niche undergoes several changes with ageing. 
Osteogenesis is reduced with a higher production of ROS. There is increase in the 
number of adipocytes which is a result of the skewed differentiation of aged 
mesenchymal stem cells and changes in the extracellular matrix (ECM) 
composition of proteins (Bellantuono et al., 2009; Freemont and Hoyland, 2007). 
The HSC niche consists of a vast array of locally secreted factors like activators 
of notch signaling, WNT ligands, stem cell factor (SCF) and TPO which have 
been discussed earlier and their contribution towards HSC homeostasis is 
significant (Lo Celso and Scadden, 2011). The skewing of aged HSC towards a 
myeloid lineage is also through the secretion of increased levels of the pro-
inflammatory CC-chemokine ligand 5 (CCL5 or RANTES). These findings 
demonstrate that the regenerative and differentiation potential of aged HSCs are 
influenced by aged niche components. An aged HSC microenvironment favours 
the expansion of pre-leukemic HSCs presumably leading to different kinds of 
myeloproliferative disorders (Vas et al., 2012a; Vas et al., 2012b). Increased 
adiposity and decreased osteogenesis may also be linked with decreased CXC-
chemokine 12 (CXCL12/ SDF1) levels in the bone marrow niche upon ageing 
(Tuljapurkar et al., 2011). Reduction of hypoxic conditions in the osteoblast niche 
through unknown mechanisms also contributes to early age associated changes in 
the HSC niche. Therefore, an aged niche may have a negative influence on HSC 
function and homeostasis. Connexin 43 (CXN 43) which forms important gap 
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junctions between HSCs and stromal cells keep the ROS levels low in HSCs to 
preserve HSC function (Cancelas et al., 2000; Gonzalez-Nieto et al., 2012). 
During genotoxic stress response which produces ROS, majority of the ROS are 
eliminated by the CXN 43 gap junction channels and are deposited in the niche 
cells. This prevents HSC senescence as the p38 MAPK and p16INK4A pathway are 
not activated thereby preserving HSC function. There might be an involvement of 
other niche factors, unidentified cytokines and adhesion molecules that crosstalk 
between the aged HSC niche and HSC intrinsic mechanisms to augment HSC 
ageing (Figure 1.6b). 
1.6.2.2 The contribution of systemic factors on HSC ageing 
The sympathetic nervous system regulates the HSC niche coordinating 
interactions of HSCs with nestin-positive (NES+) mesenchymal stem cells 
(MSCs) important for HSC mobilization and may show a different activation 
status upon ageing, although there are no reports so far, the number of NES+ 
MSCs may changes with age. Altered cell–cell communication and changes in 
adhesion receptor-mediated interactions in the aged niche and gap junction 
channels might lead to an aged phenotype in HSCs. Unidentified sympathetic 
signals promote high reduction in the function of osteoblasts following 
granulocyte colony-stimulating factor (G-CSF) (Katayama et al., 2006). 
Osteoblasts also express receptors for several neuropeptides and integrate with 
several other neuronal signaling molecules. A decrease in the number of 
osteoblasts and neuropeptides with ageing may also affect the self renewal and 




Figure 1.6b: Cell extrinsic mechanisms involved in HSC ageing. 
Many changes are associated in the HSC niche with ageing. Skewed 
differentiation of aged MSCs leads to reduced osteogenesis, increased 
adipogenesis partly due to decreased levels of CXC chemokine 12 levels in the 
niche upon ageing. Higher production of ROS and alteration of ECM composition 
induce p38 MAPK signaling in aged HSCs. Secretion of several chemokines and 
cytokines in the niche like RANTES causes skewed differentiation of aged HSCs 
towards myeloid lineage. Nestin-positive (NES+) MSCs, might contribute in the 
regulation of HSC mobilization and display an altered activation status upon 
ageing, however this is yet to proven [(Geiger et al., 2013) Nat Rev Immunol. 






1.7 Stra13, a basic helix loop helix Orange (bHLH-O) transcription factor  
Stimulated with retinoic acid gene 13 (Stra13) is member of a family of 
transcription factors called the basic helix loop helix orange (bHLH- O) factors. 
In general, bHLH proteins are a superfamily of transcription factors that function 
in various physiological processes like cellular differentiation, cell cycle arrest 
and apoptosis (Bhawal et al., 2011; Shen et al., 2002; Thin et al., 2007). bHLH-O 
group of transcription factors which constitute the repressor family of bHLH 
proteins are structurally and phylogenetically grouped into 4 mammalian 
subfamilies; the Hey, Hes, Helt and Stra13/Dec. Stra13 along with a homolog 
gene Sharp 1 belongs to Stra13/Dec under the bHLH-O superfamily (Figure 1.7). 
The bHLH-Orange transcription factors differ from other helix-loop-helix factors 
by the presence of a proline residue in their 22 basic motifs, and an additional 
orange domain for additional protein-protein interaction (Dawson et al., 1995).  
Stra13 is ubiquitously expressed during mouse embryogenesis and in adult tissues 
but its expression is regulated in a cell type specific manner (Azmi and Taneja, 
2002; Boudjelal et al., 1997; Fujimoto et al., 2001; Shen et al., 2002; Sun et al., 
2001). It was independently identified by four different groups and has been 
assigned several names; Differentiated Embryo Chondrocyte gene 1 (DEC1) in 
humans, Enhancer of Split and Hairy Related Protein 2 (Sharp2) in rat, Stimulated 
by Retinoic Acid gene 13 (Stra13) or Clast5 in mouse, E47 interacting protein 
(Eip1) and Cytokine Response gene 8 (CR8) in humans (Beadling et al., 2001; 
Boudjelal et al., 1997; Dear et al., 1997; Rossner et al., 1997; Seimiya et al., 
2002).  Stra13 is induced by several extracellular stimuli such as TGF-β, retinoic 
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acid, hypoxia, serum starvation, insulin and gonadotropins in many cells and 
tissues (Boudjelal et al., 1997; Choi et al., 2008; Ehata et al., 2007; Li et al., 2002; 
Yamada et al., 2004; Yamada et al., 2003; Yamada and Miyamoto, 2005) . 
1.7.1 Stra13 structure and domains 
Stra13 in mouse and Sharp2 in rat are made up of 411 amino acids while DEC1 
consists of 412 amino acids. Stra13 contains a bHLH motif at the N terminal 
region, a central orange domain and a proline rich domain at the C terminal 
region. The tyrosine and serine/threonine residues of Stra13 protein are 
phosphorylated and it also contains some putative phosphorylation sites which are 
acted upon by different protein kinases including casein kinase II (Boudjelal et al., 
1997; Ivanova et al., 2005). Similar to all bHLH-Orange transcription factors, 
Stra13 has a bHLH motif situated at the N terminal region of the protein. 
However, a proline residue in the basic region is displaced by two amino acid 
residues closer to the N terminus in comparison with the Hes proteins, the 
founding members of the bHLH-Orange subfamily which suggest differences in 
DNA binding affinities. The bHLH motif of Stra13 consists of the basic region 
and the helix-loop-helix region. The basic region is the DNA binding region and 
the HLH region is the dimerization domain. The HLH domain comprises of two α 
helices separated by a flexible loop, allowing Stra13 to form homodimers and 
heterodimers with other bHLH proteins and function as a nuclear transcriptional 
repressor. Stra13 recognizes and binds canonical E-box sequence, a 
hexanucleotide sequences of 5’-CANNTG-3’ (N represents any nucleotide) 
located in the transcriptional regulatory regions of its target genes. Stra13 binds to 
46 
 
sequence 5’-CACGTG-3’ in a high affinity manner and 5’-CATGTG-3’, 5’-
CACGTN-3’, 5’-CACGCG-3’ in a low affinity manner (St-Pierre et al., 2002; 
Zawel et al., 2002). The transcriptional repression activity of Stra13 is decreased 
by deletion or introduction of mutation in the basic region which demonstrates 
that the E box sequence is critical for repressive function of Stra13. The orange 
domain of Stra13 at its central region is a motif of ~35 amino acids and is a 
characteristic feature of all bHLH-Orange transcriptional factors. The orange 
domain mediates additional protein-protein interactions of Stra13 and other 
proteins (Dawson et al., 1995). The C terminus of Stra13 contains a proline rich 
region and very little is known about the function of this domain. Stra13 lacks 
tryptophan-arginine-proline-tryptophan (WRPW) tetrapeptide motif or tyrosine-
arginine-proline-tryptophan (YRPW) motif which is present in the proline rich 
region at the C terminus of Hes and Hey proteins respectively. The WRPW motif 
of Hes protein is essential for the recruitment of corepressor transducin-like 
enhancer of split (TLE), the mammalian counterpart of the Drosophila 
corepressor Groucho to enhance its transcriptional repression of genes (Fisher et 
al., 1996; Grbavec and Stifani, 1996). Stra13 which lacks WRPW motif does not 
recruit Groucho, but instead interacts with co-repressors such as HDAC1, NCoR 
and mSin3A at its C terminus to bring about gene repression (Boudjelal et al., 
1997; Sun and Taneja, 2000). C terminal truncated forms of Stra13 exhibit 
decreased transcriptional activity, indicating that both the bHLH and C terminal 
regions of Stra13 are essential for its transcriptional activity (Boudjelal et al., 




Figure 1.7: Schematic diagram showing the classification of the bHLH-O 
Transcription Factors and their domain structure. Stra13 falls under the 
Stra13/Dec sub family. It consists of a bHLH motif, an orange domain and proline 
rich C terminal domain. A unique feature of this family is the absence of the 
WRPW and YRPW motifs which are present in other members of the bHLH-O 
family [(Sun et al., 2007); Translational Oncogenomics. 2007, 2: 105-118]. 
 
1.7.2. Functions of Stra13 
Since Stra13 is ubiquitously expressed during development and in adult tissues, it 
participates in a wide variety of physiological functions from cellular 
differentiation, T cell regulation, genotoxic stress, adipogenesis, muscle 
regeneration, circadian rhythm, cancer, apopotosis and senescence. In particular, 
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the role of Stra13 in the immune system in the regulation of T and B cells will be 
disussed in greater detail. 
1.7.2.1 Role of Stra13 in the immune system 
Stra13 is expressed in resting B cells and its mRNA expression is down regulated 
upon activation of B cells by IL-4, CD40 ligand, lipopolysaccharides and other 
stimuli. Stra13 acts a negative regulator of B cell activation by delaying its entry 
into S phase of the cell cycle and repressing Fas mediated apoptosis and colony 
formation (Seimiya et al., 2002). In Stra13 transgenic mice (Stra13-Tg) ectopic 
expression of Stra13 in B and T lineage cells leads to impaired development of 
the bone marrow and thymus. The cellularity of the thymus and spleen is reduced 
when compared to their control littermates. Endogenous Stra13 expression is up 
regulated in pro B cells, down regulated in pre B cells and elevated in immature B 
cells. Nevertheless, the germinal center which contains activated B cells show 
reduced expression of Stra13 even though the expression of Stra13 is sustained in 
mature splenic B cells (Seimiya et al., 2004). However, in Stra13-Tg mice, Stra13 
expression is higher in all stages of B cell development. Similarly, its transcript is 
elevated in CD4+CD8+, CD3-CD4-CD8-, CD4+ and CD8+ cells when compared to 
control mice in the thymus. Stra13-Tg mice exhibit an inhibition of early T cell 
development in the thymus with a reduction of CD44+CD25+ and CD44-CD25+ 
pro T cell population. The frequency of interleukin 7 (IL-7) responses of the 
progenitor cells of the bone marrow especially the pro B cells shows a significant 
reduction in colony number in colony forming unit (CFU) –IL7 assay.  
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 In another study published by our lab, Stra13 knockout mice were generated, the 
knockouts were born normal, fertile with no obvious phenotype when compared 
to their wild type littermates. Young Stra13 knockouts showed a defective 
activation of T cells after being stimulated with anti-CD3 and anti-CD28 with 
decreased production of IL-2, IL-4 and IFN-γ both in vitro and in vivo.  However, 
as the knockouts aged, massive lymphoid organ hyperplasia was observed within 
6-8 months in gender dependent manner where 90% of the females and 50% of 
the males developed enlargement of the thymus, spleen and lymph nodes. The T 
and B cells were spontaneously activated with increased production of auto 
immune antibodies and immune complexes. The hyperactivated T and B cells 
infiltrated organs like the lungs and kidney and caused a systemic autoimmune 
lymphoproliferative disorder similar to systemic lupus like disease (Sun et al., 
2001). CD4+ T cells from Stra13 KO mice show reduced expression of FasL and 
were resistant to Fas mediated apoptosis and this resulted in the accumulation of 
activated T and B cells.  
In a recent report, Stra13 was found to play an important role in maintaining 
regulatory T cell (Treg) homeostasis and function. Stra13 was highly expressed in 
immature CD4-8- (double negative) population and its expression reduced in 
CD4+8+ (double positive) cells during thymocyte development. Stra13 expression 
was higher in the Treg cells (CD4+CD25+) when compared to its their non Treg 
cell compartment (CD4+CD25-). As the mice developed the autoimmune 
phenotype with ageing, a marked reduction of CD25+ or FoxP3 Treg cells among 
the CD4+T cells was observed in comparison to their wild type controls (Miyazaki 
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et al., 2010). Stra13 is required for the maintaining Treg cells in the periphery and 
for the suppression of effector T cell mediated autoimmunity and its enforced 
expression leads to increased numbers of Treg cells in vivo and upregulation of 
CD25. Further experiments showed that Stra13 binds to the positive regulatory 
regions of the IL2RA together with Runx1 in Treg cells and maybe required for 
its long term expression.  
Stra13 was one of the genes identified when naïve CD4+ T cells were 
costimulated with anti-CD28 in order to determine genes that play an important 
role in T cell activation and differentiation (Martinez-Llordella et al., 2013). 
Microarray analysis of Stra13 deficient T cells further supported that Stra13 
controls a subset of CD28 dependent genes and the expression of these genes is 
essential for the function of CD4+ conventional T cell in a mouse model of 
autoimmune encephalomyelitis (EAE) which is a CD4+ T cell mediated and CD28 
dependent inflammatory disease of the central nervous system. Immunization of 
Stra13 WT and Stra13 KO with MOG35-55 peptide in CFA to induced EAE 
demonstrated that Stra13 KO mice were completely protected from EAE when 
compared to Stra13 WT controls. Thus Stra13 is required for efficient T cell 
priming during the development of EAE. Stra13 is important for the production of 
proinflammatory cytokines during the effector phase of EAE as Stra13 KO T cells 
show reduced IL-2, GM-CSF and IFN-γ (Martinez-Llordella et al., 2013). 
Stra13 was one of the target genes identified post translationally modulating myc 
activity in human B lymphocytes by using modulator inference by network 
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dynamics (MINDy) algorithm. MINDy identified Stra13 as a negative regulator 
of myc activity. To assess the effect of Stra13 gene silencing on expression of 
myc targets, gene expression profiling was carried out. There was a significant 
enrichment of canonical myc targets within the differentially enriched genes. 
However, myc mRNA and protein levels were unchanged indicating a post 
translational effect. This established Stra13 as an antagonist of myc activity 
(Wang et al., 2009).  
Stra13 is induced and up regulated in primary human gingival epithelial cells by 
the pro inflammatory interleukin IL-1β. The induction of Stra13 by IL-1β is 
dependent upon PI3K-Akt signaling pathway linking Stra13 function to 
inflammation (Bhawal et al., 2012). 
1.7.2.2 Role of Stra13 in DNA damage stress response 
Stra13 is induced in response to genotoxic stress in the form of ionizing gamma 
radiation and genotoxic agents- etoposide and cisplatin both in vitro and in vivo in 
a p53 independent manner. Thymocytes from Stra13 knockout mice are resistant 
to ionizing radiation and show impaired apoptosis and express reduced levels of 
p53 and its downstream target Puma and Noxa.  The defective apoptosis in Stra13 
thymocytes is accompanied by a decrease in Bim and an increase in Bcl-2 levels 
compared with wild type thymocytes (Thin et al., 2007). 
1.7.2.3 Role of Stra13 in differentiation and as a growth repressor. 
Stra13 was initially identified as one of the novel retinoic acid responsive genes in 
a cDNA differential screening of P19 embryonal carcinoma cells treated with 
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retinoic acid (RA) in monolayers (Boudjelal et al., 1997). Ectopic expression of 
Stra13 in P19 cells in monolayer cultures results in neuronal differentiation as 
opposed to wild type P19 cells that generally differentiate into mesodermal and 
endodermal lineages. The decreased expression of activin, a mesodermal marker 
and increased expression of neuronal marker Wnt1 in Stra13 overexpressing cells 
showed Stra13 to function as transcriptional repressor of mesodermal 
differentiation pathway and activator of neuronal pathway under these conditions. 
Through subtractive hybridization technique, Stra13 was found to be one of the 
most important genes involved in chondrocyte differentiation when stimulated 
with Bt2cAMP, an analog of cAMP (Shen et al., 2002).  In another study, Stra13 
acts as a growth suppressor of cells when activated with different stimuli like RA, 
trichostatin A (TSA) or serum starvation. Stra13 causes growth arrest by down 
regulation of c-myc expression and arrest of cells at G2/M phase of the cell cycle. 
Stra13 negatively auto-regulates its own expression through a histone deacetylase 
(HDAC) dependent mechanism where the C terminal region containing the alpha 
helices interact with the components of the HDAC corepressor complex. A Stra13 
mutant (1-127 amino acids) for this C terminal region fails to interact with HDAC 
corepressor complex and hence cannot repress Stra13 expression. Stra13 also 
represses c-myc transcription through its promoter activity by interaction with the 
basal transcriptional machinery independent of HDAC pathway. Stra13 plays an 
important function in regulation of adipogenesis under hypoxic conditions, where 
it inhibits the PPARγ2 promoter activity and functions as an effector of hypoxia 
inducible factor 1(HIF-1) mediated inhibition of adipogenesis (Yun et al., 2002). 
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In a similar study under hypoxic conditions, Stra13 along with Sharp1 represses 
Sterol regulatory element binding protein 1c (SREBP-1c), a bHLH homodimeric 
transactivator involved in inducing several enzymes of the lipogenesis including 
fatty acid synthase. Stra13 inhibits SREBP1c by competing with SREBP1c for its 
binding to the E box located in the SREBP1c promoter or by direct protein 
interaction (Choi et al., 2008). 
Using the yeast two hybrid system, Stra13 was identified as the binding partner of 
STAT3β. Stra13 was found to bind to both STAT3β and STATα isoforms in its 
phosphorylated state. Stra13 is implicated in JAK-STAT signaling pathway and 
Stra13 activates transcription from STAT dependent cis elements. Overexpression 
of Stra13 leads to apoptosis via STAT3 dependent regulation of the Fas promoter 
and co expression of STAT3β and Stra13 results in antagonizing its pro-apoptotic 
effect (Ivanova et al., 2004). 
Stra13 transcriptionally regulates ΔNp63, the predominant isoform of p63 gene 
during keratinocyte differentiation. Stra13 physically interacts with HDAC2 
which reduces its ability to regulate ΔNp63 by preventing it from binding to the 
p63 P2 promoter. By using HDAC inhibitors or knockdown of HDAC2, the 
ability to Stra13 to modulate ΔNp63 expression is enhanced. Forced expression of 
Stra13 suppresses keratinocyte differentiation whereas knockdown of Stra13 
favors differentiation by modulating ΔNp63 regulation (Qian et al., 2011). 
Stra13 along with Sharp1 also act as repressor or the retinoic acid receptor (RXR) 
and retinoic acid receptor -liver X receptor (RXR-LXR) by interacting with RXR 
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and represses target genes meditated by RXR-LXR heterodimer. The repression 
of RXRα transactivation by Stra13 is HDAC dependent but HDAC independent 
for Sharp1. This regulatory loop between Stra13, Sharp1 and RXR heterodimers 
is important for hepatic clock system and function (Cho et al., 2009). 
Stra13 and Sharp1 (DEC family) are repressors of the miss match repair gene 
MLH1 under hypoxic conditions. It not only represses MLH1 through HDAC 
dependent mechanisms but also by direct binding to DEC response element on the 
promoter of MLH1. However, knockdown of Stra13 cannot attenuate MLH1 
repression during hypoxia as Sharp1 protein is increased due to decreased Stra13 
expression. This links the HIF-DEC pathway in controlling the expression of 
mismatch repair genes (Nakamura et al., 2008). 
1.7.2.4 Stra13 in cancer, apoptosis, cell cycle arrest and senescence  
The role of Stra13 has been widely studied in the field of cancer biology. Stra13 is 
highly expressed in a number of human cancers such as breast, colorectal, gastric 
and hepatocellular carcinomas. The endogenous expression of Stra13 or DEC1 
(human counterpart) is high in these neoplastic tissues in comparison to its non 
neoplastic ones which correlates with increased invasiveness of breast cancer and 
decreased differentiation of gastric cancer. This demonstrates Stra13 role in 
promoting tumor progression (Chakrabarti et al., 2004; Jia et al., 2013; Shi et al., 
2011). However, the differentiation status of hepatocellular carcinoma positively 




The mechanism of how Stra13 promotes and regulates cancer development is 
poorly understood. A large number of correlative studies suggest its involvement 
in diverse cancers but mechanistic studies are limited. A small number of studies 
demonstrate that Stra13 regulates apoptosis and/or cell cycle arrest in neoplastic 
and non-neoplastic cells. For example, Stra13 knockdown in MCF-7 cells upon 
paclitaxel treatment decreases cleaved poly (ADP-ribose) polymerase (PARP), an 
indication of decreased apoptotic activity (Wu et al., 2011). Stra13 knockout 
thymocytes also have impaired apoptosis upon irradiation as discussed earlier 
(Thin et al., 2007). Both studies suggest Stra13 functions as a proapoptotic 
molecule.  
Interestingly, Stra13 also functions as an anti-apoptotic protein. Stra13/DEC1 was 
identified as a downstream target of TGF-β signaling pathway promoting the 
survival of mammary carcinoma cells (Ehata et al., 2007). The antiapoptic 
function of Stra13 has also been studied in colon carcinomas where Stra13 
selectively decreases the activation of procaspases 3, 7 and 9 (Li et al., 2002). Its 
antiapoptic role is also mediated by the induction of survivin which has been 
identified as a transcriptional target of Stra13 (Li et al., 2006). Stra13/DEC1 is 
also implicated in inducing cell cycle arrest. DEC1 brings about cell cycle arrest 
by repression of Cyclin D1, an essential component required for G1/S transition 
of the cell cycle. Cyclin D1 contains a DEC response element in its promoter and 
DEC1 binds to this DEC-response element and represses transcription of Cyclin 
D1 (Bhawal et al., 2011; Wang et al., 2012b). Inactivation of DEC1 rescues its 
repression and facilitates proliferation.  Stra13/DEC1 is down-regulated in HepG2 
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cells after treatment with an apoptotic inducing compound 8-methoxypsoralen (8-
MOP), and ectopic expression of DEC1 antagonizes 8-MOP induced apoptosis 
(Peng et al., 2012). Stra13 expression is also induced by hypoxia and regulated by 
hypoxia inducible factor 1α (HIF-1α) thus promoting the survival of tumours 
(Chakrabarti et al., 2004). High Stra13/DEC1 mRNA expression is also apparent 
in various leukemic cell lines (Ivanova et al., 2001). Together these studies 
suggest a role of Stra13 in oncogenesis. 
1.7.2.5 Stra13 and senescence  
Since Stra13 regulates both cell cycle arrest and apoptosis, it has been implicated 
that this function of Stra13 is mediated by p53, a well known regulator of cell 
cycle and apoptosis.  Reports have demonstrated that Stra13 via its bHLH domain 
physically interacts with C terminal region of p53 and regulates the expression of 
P53 and enhances its stability. This is brought about by shielding the C terminus 
of p53 protein from Mdm2 mediated ubiquitination, preventing its nuclear export 
and degradation (Thin et al., 2007). 
Other studies have reported Stra13 as one of the downstream effectors of p53 in 
facilitating senescence. In response to DNA damage, p53 binds to p53 binding 
site on the Stra13 promoter to activate its transcription. Stra13 then mediates p53 
dependent premature senescence independent of the p21 senescence pathway 





1.7.2.6 Role of Stra13 in circadian rhythm 
Stra13/DEC1 along with Sharp1/DEC2 forms the fifth clock gene family and are 
regulators of the mammalian clock genes along with other members such as 
Bmal1, Cry and Per genes. Stra13 is expressed in the suprachiasmic nucleus in a 
circadian fashion. Through direct protein-protein interactions or competitive 
binding to E boxes with Clock/Bmal1, Stra13 represses the Clock/Bmal1 induced 
activation of the Per1 promoter (Honma et al., 2002). The circadian expression of 
Stra13 in peripheral tissues has also been observed in lungs, kidney, liver, heart 
and monocytes (Boivin et al., 2003; Grechez-Cassiau et al., 2004; Noshiro et al., 
2004).  
1.8 Perspectives and Aims of this Study 
The major aim of my thesis is to study the role of Stra13 in hematopoiesis. 
Reports from our lab and others have shown that Stra13 plays an important role in 
the regulation and homeostasis of regulatory T cells (Miyazaki et al., 2010; Sun et 
al., 2001). Other reports suggest Stra13 acts as a negative regulator of B cell 
activation by delaying its entry into the S phase of the cycle and repressing Fas 
mediated apoptosis (Seimiya et al., 2002). However, the role of Stra13 in 
hematopoiesis has not been investigated so far. The first part of my thesis 
demonstrates that Stra13 is expressed in the long term (LT)-HSCs and short term 
(ST)-HSCs. Using knockout mice, we have identified that Stra13 is dispensable 
during steady state hematopoiesis. With ageing, Stra13 knockout mice show a 
reduction in the percentages of both LT-HSCs and ST-HSCs and altered 
progenitor cell levels. With the help of microarray analysis we have identified 
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potential target genes which may play a role in hematopoietic stem cell ageing in 
Stra13 KO mice.  
The second objective of my thesis is to study the role of Stra13 in hematopoiesis 
during genotoxic stress. Genotoxic stress in the form of ionizing radiation or 5-
Fluoro Uracil, a myeloablative drug has been well used in clinical settings for 
bone marrow disorders. Through our studies in hematopoietic cells we have 
demonstrated that the LSK cell compartment of Stra13 knockout mice is sensitive 
to both forms of genotoxic stress. Through gene expression profiling studies we 
have identified potential target genes which could potentiate the role of Stra13 in 
stress response in HSCs by ionizing radiation. Our data uncovers a novel role of 
Stra13 in stress response and provides further evidence of the emerging role of 











MATERIALS AND METHODS  
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    2. MATERIAL AND METHODS 
2.1 Stra13 Knockout Mice 
Stra13 knockout mice (KO) have been described previously (Sun et al., 2001). 
Stra13 KO mice were maintained in C57BL/6 background in a SPF mice facility; 
MD2 Vivarium at National University of Singapore (NUS) and all mice 
experiments followed strict procedures set according to Institutional Animal Care 
and Use Committee (IACUC) guidelines at NUS. In general Stra13 heterozygous 
mice were crossed to generate Stra13 KO and Stra13 wild type (WT) littermate 
controls which were used for experiments as described below.  
2.2 Isolation of cells from the bone marrow, spleen, thymus and peripheral 
blood 
Bone marrow (BM cells) was isolated from 8-12 weeks old C57BL/6 CD45.2 WT 
mice from the hind limbs (femur and tibia), forelimbs (humerus) and hips (ilium). 
The muscles and connective tissues were removed and the bones were crushed in 
a mortar and pestle in PBS containing 2% FBS. Similarly spleen and thymus were 
minced in PBS with 2% FBS. The cell suspension from the bone marrow, spleen 
and thymus were passed through a 45 µm filter and RBCs were lysed with 
Ammonium Chloride Potassium (ACK) buffer. Peripheral blood was collected by 
retro orbital puncture into EDTA or heparin coated capillary tubes and RBCs 
lysed with ACK buffer. 
BM cells, splenocytes and thymocytes from young (2-3 months) and aged (13-16 
months) Stra13 WT and KO mice were isolated in the same manner as above. The 
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samples were then stained with antibodies for specific surface markers for either 
flow cytometric analysis or flow cytometric sorting as described below.  
2.3 Flow Cytometric analysis of Bone Marrow (BM) cells and Sorting 
BM cells were treated with a lineage marker cocktail consisting of PECy-7 
conjugated anti-Gr1, Mac1, B220, CD3, CD4, CD8 CD19 and Ter119 
monoclonal antibodies (mAbs) and incubated on ice for 30 minutes. For sorting of 
cells into SLAM, LSK, GMP, CMP and MEP, lineage positive (Lin+) cells were 
depleted using Dynabeads Sheep anti-Rat IgG (Invitrogen) and passed through a 
magnetic column. Lineage negative (Lin-) cells were stained with FITC 
conjugated anti-CD34, PE conjugated anti-CD16/32 (FcGRIII/II), APC 
conjugated anti-CD117 (c-Kit) and APC-Cy7 conjugated anti Sca1 (Ly6A/E) 
monoclonal antibodies which are markers for progenitors –LSK, CMP, GMP and 
MEP. For SLAM markers, BM cells were stained with PE conjugated anti CD150 
and FITC conjugated anti CD48. The LT-HSCs and progenitors were either sorted 
or analyzed for their percentages in the bone marrow. Spleen cells were stained 
for T cells (CD3) and B cells (CD19, CDB220). Thymus was stained for CD4 and 
CD8 antibodies respectively. Dead cells were excluded by a combination of 
scatter gates and by propidium iodide or DAPI staining. All mAbs were 
purchased from BD Biosciences and eBioscience. Multi color sorting and analysis 
was performed using Becton Dickinson (BD) FACS ARIA and BD LSRII 




2.4 Cloning of Retroviral Construct 
The MIG retroviral vector (MSCV-IRES-GFP), a kind gift from Professor Daniel 
G. Tenen was used for cloning mouse Stra13. The MIG vector is composed of 
MSCV (murine stem cell virus) LTRs (long terminal repeat), IRES (internal 
ribosome entry site) and GFP (green fluorescent protein) gene. MSCV-Stra13-
IRES-GFP (pMIG-Stra13) construct to overexpress Stra13 was made by sub 
cloning mouse Stra13 ORF from pCS2-Myc-Stra13 into the EcoR1 site of MIG 
vector using standard procedures. The pMIG-Stra13-GFP construct was 
sequenced to confirm its sequence orientation and amplified by maxi prep for 
further downstream experiments. 
2.5 Bacterial transformation and plasmid DNA extraction 
100 ng of plasmid DNA construct was incubated with 50 μl of DH5α competent 
cells (Invitrogen) on ice for 30 minutes prior to heat shock treatment at 42°C for 
90 seconds and snap cooled on ice for 2 minutes and then cultured with 1 ml of 
Luria-Bertani (LB) broth for 1 hour at 37°C with constant shaking at 250 rpm. 
The cells in the LB broth were pelleted by centrifugation at 8000 rpm for 1 
minute and resuspended in 200 μl of fresh LB broth and plated on LB agar plates 
supplemented with ampicillin (100μg/ml). The plates were then incubated 
overnight at 37°C to obtain bacterial colonies containing the transformed DNA 
plasmid constructs. Individual colonies of transformed bacterial cells were 
innoculated into 2 ml of LB broth supplemented with ampicillin (100μg/ml) and 
incubated at 37°C for 7-9 hours in an orbital shaker at 37°C at 250 rpm. The 
turbid starter culture was then transferred into a 300 ml of LB-ampicillin and 
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grown overnight in an orbital shaker at 37˚C at 220 rpm for 16 hrs. The following 
day, the bacterial cells from the overnight culture were pelleted by centrifugation 
at 5000 rpm for 5 minutes at 4°C. The supernatant was decanted and plasmid 
DNA extraction from the bacterial pellet was carried with Qiagen Plasmid Midi 
kit (Qiagen) according to manufacturer’s instruction. The bacterial pellet was 
resuspended completely in 4 ml of buffer P1 (with RNaseA added) and 
thoroughly lysed. The bacterial cells were lysed using 4 ml of buffer P2 by 
vigorously inverting the sealed tubes 4-6 times and incubated at room temperature 
for 5 minutes. Pre-chilled buffer P3 was then added to the lysate mixed 
thoroughly and was incubated on ice for 15 minutes. The lysate was centrifuged at 
15000 rpm for 15 minutes at 4˚C; the clear supernatant was then collected in 
another 50 ml eppendorf tube. The Qiagen midi column was equilibrated with 4 
ml of buffer QBT. The cleared lysate was filtered into the pre-equilibrated 
column. The column was washed with 10 ml of buffer QC twice to exclude the 
contaminants. The DNA was eluted using 5 ml of buffer QF, precipitated by the 
addition of 3.5 ml isopropanol and centrifuged at 13,000 rpm for 30 minutes at 
4˚C. The supernatant was carefully decanted and the DNA pellet was washed with 
2 ml of 70% ethanol; centrifuged further at 13,000 rpm for 10 minutes at 4˚C. The 
pellet was air-dried and dissolved in RNase-DNase free water. The concentration 
of DNA was measured by Nanodrop spectrophotometer (NanoDrop-1000, 




2.6 Transfection and production of retrovirus for murine bone marrow 
infection  
BOSC23 cells, a retrovirus packaging cell line cultured in DMEM supplemented 
with 10% FBS were transfected with the retrovirus constructs pMIG and pPMIG-
Stra13 and virus helper structural plasmids- gag and pol with lipofectamine 2000 
(Invitrogen) according to the manufacture’s instruction. The virus supernatants 
were collected after 48 hours and 72 hours post transfection and concentrated as 
described (Zelenock et al., 1997). In brief, the retrovirus medium was collected at 
48 and 72 hours, pooled and passed through a 0.45 µm syringe filter to exclude 
the cell debris. The supernatant were then transferred to a sterile specialized tube 
and centrifuged at 6000g for 16 hours at 4°C. The supernatant was discarded and 
the fine pellet was resuspended in 1 ml of serum free DMEM and stored in 
aliquots at -80°C until further use. The virus titers for the MSCV retroviral 
supernatants were estimated by transduction of NIH3T3 cells and quantifying the 
percentage of GFP-positive cells by flow cytometry analysis (Appendix II). 
2.7 Retrovirus infection of bone marrow and bone marrow progenitors  
8-12 week old C57BL/6 mice (CD45.2, n=3) were intraperitoneally injected with 
150 mg/kg of 5-FU. After 5 days, the bone marrow was isolated from the femurs 
and tibia of treated mice. RBC lysis was performed and the bone marrow was 
stained with a lineage cocktail of antibodies for PE-Cy7 conjugated anti CD3, 
CD9, CD4, CD8, Gr1, Mac1, B220 and Ter119 (Lin+ cells). Lineage depletion 
was performed with Dynabeads Sheep anti-Rat IgG (Invitrogen) and passed 
through a magnetic column. Lineage negative (Lin-) cells were stained with APC 
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conjugated anti-CD117(c-Kit) and APC-Cy7 conjugated anti-Sca1 mAbs and 
sorted for LSK cells under aseptic conditions. For infection of LSK progenitors, 
the retrovirus medium was placed in 35mm non tissue culture dishes for 3 hours 
precoated with 15 ug/ml of retronectin (Takara Bio) at room temperature for 2.5 
hours. The sorted LSK cells were plated for infection for 48 to 60 hours with the 
coated retrovirus containing pMIG-Stra13 or an empty vector as control. The 
retrovirus infection was carried out at a multiplicity of infection (MOI) =20 in a 
rich cytokine cocktail containing IL3 (10 ng/ml), IL6 (10 ng/ml), SCF (50 ng/ml), 
TP0 (25 ng/ml) and FLT3 (50 ng/ml) (all from Peprotech) in hematopoietic stem 
cell expansion medium (Stem Cell Technologies) supplemented with 15% FBS 
(Hyclone).  
2.8 Mouse Bone marrow transplantation 
Sorted LSK cells (1.5 x 104-2.0 x 104) / mouse isolated from C57BL/6 (CD 45.2) 
mice infected with Stra13 retrovirus or mock retrovirus were transplanted via tail 
vein injections into lethally congenic mice C57BL/6-CD45.1 mice. A total 
radiation dose of 10.5 Gy was given in two doses of 5.75 Gy each separated by 3-
4 hours to prevent damage to the gut cells. 2 x105 of C57BL/6-CD45.1 
splenocytes were transplanted together with the bone marrow LSK cells to 
provide radioprotection. All animal studies were approved by IACUC of National 
University of Singapore. The animals were monitored closely on a regular basis. 
Peripheral blood was obtained at different time points after transplantation by 
puncture of the retroorbital venous sinus using heparin or EDTA coated micro 
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capillary tube. Peripheral blood count was analyzed using Hemavet 950 auto 
analyser (Drew Scientific). 
2.9 Flow Cytometric Analysis of peripheral blood after transplantation.  
RBCs from peripheral blood were lysed with ACK buffer. The cells were washed 
with PBS and stained with respective antibodies for mature myeloid and 
lymphoid markers PE-Cy7 Gr-1, APC-Mac1, PE-Cy7 CD19 and APC CD3 at 
4°C for 45 minutes. Flow cytometric analysis of the stained cells was performed 
using BD LSRII and the data analyzed using the BD FACS Diva software. 
2.10 Competitive Repopulation Assays in young Stra13 knockout mice 
Competitive repopulation assays were carried out as previously described (Capron 
et al., 2006). C57BL/6 (CD45.1) mice were used as recipients and were lethally 
irradiated (10.5Gy) in two split doses of 5.75 Gy 3-4 hrs apart. They received 
different doses of bone marrow test cells from Stra13 WT or Stra13 KO:-5 x 106 
and 0.5 x 105 cells along with a fixed number of competitor cells 1 x 106 from 
CD45.1/CD45.2 mice corresponding to ratios of 5:1 and 0.5:1 respectively. 
Young Stra13 KO and WT littermate controls (2 months) were used as donors for 
this assay. Hematopoietic reconstitution was assessed at 4 and 8 weeks through 
peripheral blood analysis. The mononuclear cells from the peripheral blood were 
stained with anti PE conjugated CD45.2 and eFlour450 anti CD45.1 mAbs and 
analyzed by flow cytometry. Reconstitution of ganulocytes (Gr1), B cells (CD19) 




2.11 Colony forming assays  
Stra13 was overexpressed by retroviral transduction in sorted LSK cells isolated 
from 8-12 weeks old C57BL/6 mice. The infection was carried out on coated 
retronectin 35 mm dishes with the mock empty vector control for two consecutive 
days and GFP+ cells were sorted aseptically after 48 hours. GFP+ cells were 
cultured in vitro for another 3 days. 1000 GFP+ were plated in Methocult medium 
containing the rich cytokine cocktail of human transferrin, recombinant stem cell 
factor (SCF), IL3, IL6 and erythropoietin (M3434, Stem Cell technologies). 
Colonies were scored under a microscope after 7 days of culture. 
2.12 Real Time PCR  
Total RNA was extracted from murine sorted bone marrow progenitors- LSK, 
CMP, GMP and MEP using the RNeasy micro kit (Qiagen) according to the 
manufacture’s instruction and converted to cDNA using a high fidelity reverse 
transcriptase (Roche). Real Time PCR was performed using Corbett Rotor Gene 
6000 using the two step method and cDNA amplified by using SYBR Green Mix 
(Applied Biosystems). The following primer pairs were used: 
mStra13:   Forward 5’-GCCCTGCAGAGCGGTTTACAAA-3’ 
         Reverse 5’-GAGCCGAGTCCAATGGTTTCCTG-3’ 
mGAPDH: Forward-5’- GACATGCCGCCTGGAGAAAC-3’  
       Reverse- 5’-AGCCCAGGATGCCCTTTAGT-3’ 
67 
 
QPCR reaction was performed in triplicates to obtain CT values. Relative gene 
expressions were calculated according to the ΔΔCt method. Expression levels of 
Stra13 were normalized with GAPDH mRNA expression level. 
2.13 Genotoxic / DNA damage response in LSK cells by gamma radiation 
and 5 Fluorouracil (5-FU) 
2.13.1 Sublethal Gamma Radiation: Young Stra13 KO mice and its littermate 
WT control were subjected to a sub lethal dose of 5Gy whole body gamma 
radiation. After 24 hours, the mice were euthanized and the bone marrow was 
stained with antibodies for flow cytometric analysis of LSK cells as described 
under methods 2.3. 
2.13.2 Myelotoxic drug 5-FU: Young Stra13 and its wild type littermate control 
were injected with 150 mg/kg of 5-FU (Sigma Aldrich) intraperitoneally. After 7 
days, the mice were sacrificed and the bone marrow was stained with antibodies 
for flow cytometric analysis of LSK cells as described under methods 2.3. 
2.14 Microarray and gene expression analysis 
Total RNA was extracted from 2 biological replicates from the sorted LSK cells 
under each condition (radiation and old age) with RNeasy micro kit (Qiagen). The 
concentration and the purity of the extracted RNA was obtained using Nanodrop 
1000 (Thermo Fisher Scientific) and the integrity of RNA was confirmed using 
Bioanalyzer (Agilent Technologies, USA). Total RNA was amplified with Target 
Amp Pico kit for Illumina expression Beadchip (Epientre, Illumina). Reverse 
transcription to cDNA was done with 500 ng of extracted RNA using 
SuperscriptTM II Reverse Transcriptase (Invitrogen) primed with T7-(dT)-24 
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primer. cRNA was then transcribed in vitro from cDNA as biotin-labelled, in the 
presence of T7 RNA polymerase and biotinylated ribonucleotides (Enzo 
Diagnostics, USA). 500ng was reverse transcribed into cDNA followed by in 
vitro transcription to biotin-labeled cRNA using the Illumina TotalPrep RNA 
Amplification kit (Applied Biosystems). 750 ng of each cRNA sample was 
hybridized to mouse WG-6 v2.0 Expression BeadChip microarrays (Illumina) for 
16 hours at 58°C. After the incubation period, the arrays were washed and stained 
with Streptavidin-Cy3 (GE Healthcare), followed by scanning the arrays using 
Illumina Bead Array Reader (Illumina) at 25 scan factor 1. The signal values of 
cRNA bound to each probe was further translated into gene expression values 
using Partek® Genomics Suite™ version 6.5 (Partek Inc., USA). Background 
subtraction was applied on raw intensity values and subsequent data was 
subjected to quantile normalization on the Beadstudio Data Analysis platform 
(Illumina) with a normalized expression value cutoff at 100. Principal component 
analysis was performed before analysis of gene expression to ensure quality 
control. Analysis of variance (ANOVA) was conducted on the complete data set 
and a list of differentially expressed genes was obtained with p < 0.05. 
Unsupervised two-dimensional average-linkage hierarchical clustering of the 
genes, differentially expressed was performed for both the cell types by using 
Spearman’s correlation as similarity matrix. Biological significance of the 
differentially expressed gene list was better realised by classifying the genes 
based on their biological pathways and molecular functions using DAVID 
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(Database for Annotation, Visualization and Integrated Discovery v6.7 (Huang da 
et al., 2009a; Huang da et al., 2009b).  
2.15 Stra13 mice genotyping  
For genotyping of Stra13 mice, mice tails were clipped during the weaning period 
(21 days). The mice tails were digested with proteinase K buffer overnight at 
55°C (200 µg/ml) and the genomic DNA was isolated by phenol chloroform 
extraction. A semi-quantitative genomic DNA PCR was carried out to identify the 
genotypes of the mice using the following Stra13 primers: 
Primer 1: 5’-CGTTTTATTCCCCGCCTGGA-3’ 
Primer 2: 5’-GGAAGCTCAGGCTAGCTCAT-3’ 
Primer 3: 5’-TCGATTCCACCGCCGCCTTCTATG-3’ 
Primers 1 and 2 detect the wild type allele. Primers 2 and 3 detect the knockout 
allele. The PCR conditions were as follows: 94 °C -5 minutes, 94 °C -30 sec, 
58°C - 45 sec, 72°C -1 min, 72 °C -5 min for final extension and 4°C cooling step 
for a total of 29 cycles. The PCR products were run on a 1.5% agarose gel and the 
gels images were captured using Bio-Rad ChemiDoc™ XRS Gel Documentation 
system. (Appendix III) 
 
2.16 Statistical Analysis 
Statistical significance was determined by a 2-tailed parametric Student’s t test 
(Graph Pad Prism software and Microsoft Excel). A P value less than 0.05 was 
considered significant. Data are shown as the mean ± SD unless otherwise 
indicated in the legend. Different degrees of statistical significances were 















         3. RESULTS 
3.1 Role of Stra13 in hematopoietic stem cell regulation 
3.1.1. Analysis of expression of Stra13 in the bone marrow progenitors and 
long term hematopoietic stem cell during steady state hematopoiesis. 
Our lab has previously published that Stra13 is induced upon T cell activation 
(Sun et al., 2001). As a first step in addressing the role of Stra13 in hematopoiesis, 
we investigated Stra13 expression in the different mouse progenitor populations. 
Bone marrow cells from C57/BL6 wild type mouse (8-12 weeks) were sorted by 
flow cytometry into the different progenitor fractions namely LSK, CMP, GMP 
and MEP based on their surface marker characteristics. A flowchart explaining 
the FACS sorting strategy of SLAM+ cells, LSK cells and the multipotent 
progenitor cells- CMP, GMP and MEP are represented in Figure 3.1.1a. After 
sorting, total mRNA levels were examined by quantitative real time PCR (q-PCR) 
which showed highest expression of Stra13 in the LSK population and lowest in 
the MEP fraction of the bone marrow when compared to the other progenitors 
(Figure 3.1.1b).  
Since the LSK progenitors are heterogeneous and consist of both short term (ST) 
and long term (LT) HSCs respectively, we checked the expression of Stra13 in the 
SLAM+ fraction which consists mainly of LT-HSCs which are considered to be 
the purest form of HSCs characterized by the expression of surface markers 
CD150+ and CD48-. Stra13 expression was higher in the SLAM+ cells compared 
to the SLAM- fraction (Figure. 3.1.1c). This suggests that the Stra13 expression 










Figure 3.1.1: Stra13 expression in multipotent bone marrow progenitors and 
hematopoietic stem cells.  
a) Strategy for sorting the different stem and progenitor fractions by flow cytometry with 
their respective gating based on the expression of the different surface markers used. 
b) Quantitative Real Time PCR of Stra13 mRNA expression in the different mouse bone 
marrow progenitors; LSK, CMP, GMP and MEP of 8-12 weeks old wild type C57BL/6 
mice. c) Quantitative real time PCR for Stra13 expression in the long term HSC 
compartment- SLAM+ cells (CD150+ CD48-) and SLAM- cells (CD150- CD48+). The 
expression of Stra13 mRNA is normalized to mouse GAPDH which was used as a 
control. Data is represented as mean ±SD for two independent sort experiments from 3-4 
pooled C57BL/6 bone marrow.  
 
3.1.2 Expression of Stra13 in HSCs during ageing 
 
Knowing that Stra13 is expressed in the LSK and SLAM+ fraction of the bone 
marrow during steady state hematopoiesis in young mice, we were interested to 





C57BL/6 mice (a kind gift from Professor Lim Kah Leong) were obtained and 
bone marrow was isolated and sorted for SLAM+ fraction (CD150+ CD48-) along 
with young (2-3 months) as controls. Stra13 mRNA expression was ~2.5 fold 
higher in the LSK progenitor fraction of old aged mice compared to young mice 
(Figure 3.1.2). These results suggest that Stra13 expression may be modulated and 
may play an important role in regulating hematopoietic stem cell function during 
ageing. 
 
Figure 3.1.2: Stra13 expression is upregulated in the progenitor fraction of 
aged mice. 
Comparison of Stra13 expression by real time PCR in the bone marrow progenitors of 
young and aged wild type C57BL/6 mice. The expression level of Stra13 mRNA was 
normalized to mouse GAPDH expression. Data is represented as a pool of 2-3 sorted 
fractions of bone marrow from young and aged wild type mice. 
 
3.2 Stra13 is dispensable in promoting differentiation of progenitors by 
colony forming assays  
From the above data as Stra13 was expressed in the LSK progenitor fraction, we 
proceeded further to study the clonogenic capacity and differentiation potential by 
overexpression of Stra13 in the LSK progenitors. Stra13 was overexpressed in the 
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LSK fraction by retroviral infection along with its mock control as described 
(section 2.7) and the GFP+ cells were flow-sorted and cultured in vitro for 3 days 
before subjecting them to methylcellulose assay. Colonies were counted after 7 
days of culture in the semi-solid medium containing a rich cocktail of 
hematopoietic cytokines, IL3, IL6, SCF and erythropoietin. No drastic changes 
were seen in the number of colonies in Stra13 expressing cells though the 
numbers were moderately higher (not significant) compared with the empty 
vector control (Figure 3.2) 
 
Figure 3.2: Colony forming assay with Stra13 overexpressed in LSK 
progenitors. 
Colony forming assay from LSK cells infected with Stra13 retrovirus or mock virus. 
Total colonies and GFP+ colonies were counted at the end of 7 days. No significant 
changes in the number of colonies between Stra13 and mock control (n=3). 
 
3.3. Stra13 is dispensable during steady state hematopoiesis 
3.3.1 Mature differentiated markers of all hematopoietic lineages is similar in 
young Stra13 KO mice 
We used the Stra13 KO mice to investigate whether its loss affects hematopoiesis. 
Stra13 KO mice are born normal with no apparent phenotype when compared to 
its littermate control. Our first step to study if any changes occur in the 
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hematopoietic system in Stra13 KO mice was to measure the blood counts for any 
visible differences in different blood parameters. Peripheral blood was isolated 
from the retroorbital sinus and the different blood parameters like WBCs, platelets 
and hemoglobin levels were analyzed. No significant differences were observed 
between young (2-3 months) Stra13 KO and WT littermate peripheral blood 
levels. (Figure 3.3.1a) 
 We then proceeded further to analyze the bone marrow of Stra13 KO mice. The 
differentiated populations of i.e. the granulocytes, lymphoid cells T and B cells 
were examined in the bone marrow, spleen and thymus. They were stained with 
the respective mAbs and were analyzed for their percentages by flow cytometry. 
Consistent with our previous studies (Sun et al., 2001) no changes in lymphoid 
(Figure 3.3.1b&c) and myeloid (Figure 3.3.1c) cells were apparent in Stra13 KO 








Figure 3.3.1: Similar percentages of lymphoid and myeloid cells and T cells 
in the bone marrow, spleen and thymus by flow cytometry in young Stra13 
KO mice. 
a. Peripheral blood analysis of Stra13 KO and WT control isolated from the retrorbital 
venous sinus using automated blood analyzer. (n=6 mice for each genotype).   
b. The bone marrow and spleen of Stra13 KO and WT control was stained with 
antibodies specific for B cells (CD19) and T cells (CD3) and analyzed by flow 
cytometry. No significant differences were observed between them. (n=3 mice for each 
genotype). 
c. The bone marrow was stained with markers for myeloid cells -granulocytes 
(Gr1/Mac1) and the thymus for T cells (CD4 and CD8). No apparent differences in 








3.3.2 Normal percentages of hematopoietic progenitors and LT-HSCs in 
young Stra13 KO mice 
Since we did not observe any significant differences in the percentages of mature 
lineage makers of the myeloid and lymphoid lineages, we investigated further to 
study the bone marrow progenitor fraction namely the GMP, CMP, MEP, LSK 
and CLP of Stra13 KO mice. After lineage depletion, the bone marrow was 
stained with antibodies specific for the progenitors. We went ahead further to 
analyze the LT-HSCs i.e. SLAM+ represented by the expression of surface 
markers CD150+ CD48-.  The percentage of the all the progenitors and SLAM+ 
cells in Stra13 null mice was similar to their wild type controls (Figures 3.3.2a & 
3.32b.). This suggests that the loss of Stra13 has no effect on maintaining the 
numbers of HSCs or differentiation of their progenitors and hence Stra13 might 






Figure 3.3.2 Stra13 loss has minimal effects on hematopoietic progenitors 
and LT-HSCs in young mice. 
a. Lineage depleted cells are stained with fluorochrome conjugated antibodies specific for 
LSK, SLAM (LT-HSCs), GMP, CMP and MEP and analyzed by flow cytometry. Loss of 
Stra13 has no overt differences in the percentages of the progenitors and LT-HSCs in 
young mice. Flow cytometry plots are referred to the Lin-cKithiSca1- gate, in which CMPs 
are defined as CD34+/loCD16/32int, GMPs as CD34+CD16/32+, and MEPs as 
CD34-CD16/32-. LSK cells are Lin- Sca1+cKit+. LT-HSCs are defined as LSK, 
CD150+CD48-. Representative plot of n=3 mice. 
b. Lineage negative/depleted cells were gated for IL7aR surface marker and subgated for 
cKit-Sca1 positive population for CLP. As seen, no major changes or differences in CLP 






3.4 Competitive Repopulating Assay (CRA) is similar in Stra13 KO mice to 
WT control 
The gold standard for studying hematopoietic function in vivo is the competitive 
reconstitution assay as described (section 2.10). To determine if Stra13 is required 
for the function of primitive hematopoietic cells, we carried out competitive 
repopulation transplantation to assess the repopulating ability of Stra13 KO bone 
marrow cells in comparison with its wild type control. Donor bone marrow cells 
(C57BL/6-CD45.2) from wild type and Stra13 KO mice in the following ratios 
(0.5:1, and 5:1) were transplanted into lethally irradiated C57BL/6 CD45.1 
(congenic) recipient mice. A fixed dose of competitor cells from CD45.1/CD45.2 
mice were transplanted together with the donor cells. Chimerism and repopulation 
of the bone marrow donor cells was assessed by flow cytometry. The different 
time points of analysis were 4 and 8 weeks. At 4 and 8 weeks after 
transplantation, the donor cell ratio calculated as (donor cells/donor 
cells+competitor cells) were comparable between the WT and Stra13 KO donor 
cells. At 8 weeks post transplantation, flow cytometric analysis of the transplanted 
recipients revealed that Stra13 KO and WT BM cells were equally capable of 




             
 
 
Figure 3.4 Competitive Repopulation Assay is similar in Stra13 KO and WT 
bone marrow cells.  
The graph depicts the ratio of donor cells WT (blue dots) and Stra13 KO donor cells (red 
dots) at 4 weeks and 8 weeks after transplantation with different  BM cell numbers 5x106 
and 0.5x106 along with a fixed number of competitor cells 1x106 transplanted. Graphs 
represent data for two different cell doses 5x106 and 0.5 x 106 bone marrow cells 
transplanted into 3 recipient mice for each cell dose. (n=3 mice for each genotype) 
 
3.5 Overexpression of Stra13 in LSK and transplantation has little effect on 
self renewal and differentiation 
Since loss of function of Stra13 did not reveal any discernible hematopoietic 
phenotype, we overexpressed Stra13 in the LSK population and transplanted into 
recipient bone marrow to investigate if it has any effect on short term and long 
term HSC renewal. Stra13 was cloned into a retrovirus vector MSCV-IRES-GFP. 
LSK ells from a pool of 2-3 WT mice were flow sorted under aseptic conditions, 
infected with Stra13 retrovirus or with its mock control twice on retronectin 
coated plates with MOI=20. They were transplanted into lethally radiated (10.5 
Gy) congenic (CS45.1) mice. Splenocytes from congenic mice were transplanted 
together to provide short term radio protection. Mouse peripheral blood from the 
transplanted mice was analyzed at different time points to check for transduction 
efficiency by monitoring GFP+ cells and surface marker expression of mature 
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myeloid and lymphoid markers. At 12 weeks post transplantation, high GFP+ cells 
in both B cells and granulocytes were observed in Stra13 overexpressing mice 
compared to their mock control but the overall percentages of B cells and myeloid 
cells did not vary much with respect to the mock transplanted mice (Figure 3.5a). 
At 18 weeks post transplantation, the GFP+ cells remained high in the B cells 
which might suggest better reconstitution and differentiation towards B cell 










Figure 3.5: Similar reconstitution of myeloid and lymphoid cells in Stra13 
overexpressing mice compared to WT control carried out by flow cytometric 
analysis of peripheral blood. 
a&b. Mouse peripheral blood was isolated by retroorbital puncture and analyzed by flow 
cytometry for mature myeloid (Gr-1 Mac-1) and lymphoid markers (CD19 for B cells) 
and (CD3 for T cells) by flow cytometry at 12 weeks (a) and 18 weeks (b) post 
transplantation. (n=4 for WT and n=5 for Stra13 KO mice analyzed)  
 
3.6 Ageing Stra13 knockout mice exhibit reduced percentages of long term 
HSCs and progenitors 
3.6.1 Mature differentiated markers of all hematopoietic lineages are similar 
in aged Stra13 KO mice 
Our previous results have demonstrated that the loss Stra13 has minimal effects 
on the hematopoietic system with no visible phenotype. As Stra13 expression is 
upregulated in the LSK progenitors during ageing, we were interested to 
understand whether loss of Stra13 has any role to play during ageing. Stra13 KO 
and their WT littermate control were aged for 12-14 months. Similar to young 
Stra13 mice, the peripheral blood was isolated to check the levels of WBCs, 
platelets and hemoglobin. The mature markers of the myeloid and lymphoid 
lineage were analyzed by flow cytometry in a similar way as the young Stra13 
KO mice. Interestingly, similar to young Stra13 young knockouts, aged Stra13 
KO had very little changes in the peripheral blood counts with respect to WBCs, 
platelets and hemoglobin levels. Similarly the percentages of lymphoid cells- T 
and B cells and the myeloid cells- granulocytes in ageing Stra13 KO mice were 













Figure 3.6.1: Similar percentages of lymphoid and myeloid cells and T cells 
in the bone marrow, spleen and thymus by flow cytometry in aged Stra13 
KO mice. 
a. Using an automated blood counter, the different blood parameters were measured in 
ageing (12-14 months) Stra13 KO mice and ageing WT controls (n=5 for each genotype). 
b. The bone marrow and spleen of aged 14 months Stra13 KO and WT aged littermate 
controls were stained with antibodies specific for B cells (CD19) and T cells (CD3) and 
analyzed by flow cytometry. No significant differences were observed between them. 
Representative plots for n=3 mice analyzed. 
 c. The bone marrow cells were stained with markers for myeloid cells -granulocytes 
(Gr1/Mac1) and the thymus for T cells (CD4 and CD8). No apparent differences in 
percentages were observed between aged Stra13 KO and WT littermate mice.  
Representative plots for n=3 mice analyzed. 
 
3.6.2. Decreased bone marrow stem and progenitor cells in aged Stra13 KO 
mice  
Further investigation into the bone marrow progenitors of ageing Stra13 KO mice 
showed a reduction in the percentages of the LSK by approximately 1.8 fold. It 
has been reported that differentiation is skewed towards the myeloid lineage in 
ageing mice (Beerman et al., 2010). Compared to WT ageing mice which clearly 
demonstrated myeloid bias as observed by the increase in GMP percentage, 
Stra13 KO mice infact showed reduction in the percentage of GMP by almost 
50%. Likewise there was a 50% increase in the percentage of CMP and a 




compared to WT (Figure 3.6.2a). The SLAM+/LT-HSCs which are subgated from 
the LSK fraction in Stra13 KO mice also reduced by 1.3 fold compared to 
littermate control (Figure 3.6.2a). These results indicate that the loss of Stra13 has 
its dominant effect on the HSC and progenitor population in aged animals. The 
reduction of different progenitor cell populations predominantly originated from a 
reduced number of LT-HSCs. The described stem and progenitor abnormalities 






Figure 3.6.2 Decreased HSC pool and progenitor cells in aged Stra13 KO 
mice  
a. Lineage depleted cells are stained with fluorochrome conjugated antibodies specific 
for LSK, SLAM (LT-HSCs), GMP, CMP and MEP and analyzed by flow cytometry. 
Ageing causes a decline in the numbers of LSK and SLAM+ cells and an alteration of the 
progenitor fractions in Stra13 null bone marrow when compared to their littermate aged 
controls. Representative plots of n=3 mice analyzed. 
Flow cytometry  plots are referred to the Lin-cKithiSca1- gate, in which CMPs are defined 
as CD34+/loCD16/32int, GMPs as CD34+CD16/32+, and MEPs as CD34-CD16/32-. LSK 
cells are Lin- Sca1+cKit+. LT-HSCs are defined as LSK, CD150+CD48-. 
b. Lineage negative/depleted cells were gated for IL7aR surface marker and subgated for 
cKit-Sca1 positive population specific for CLP. Moderate reduction in CLP population in 




3.7 LSK fraction of Stra13 KO mice is sensitive to genotoxic stress 
Our previous results demonstrated that ageing Stra13 KO mice have reduced LSK 
percentages; hence we investigated further whether the stress response in the 
hematopoietic compartment in the absence of Stra13 has any effect on the stem 
and progenitor cell compartment. Young Stra13 KO mice and their WT littermate 
controls were subjected to a single sublethal dose of whole body irradiation (5Gy) 
and the HSC compartment was analyzed after 24 hours (shorter duration of 6 hrs 
and 12 hrs did not reveal differences between KO and WT mice) by flow 
cytometry. Similarly, the myelotoxic drug 5-FU (150mg/kg) was intraperitoneally 
injected and the HSC compartment was analyzed by flow cytometry after 7 days. 
Pilot experiments were performed to record peripheral blood counts every 3 days 
for up to one month after 5 FU injections (data not shown). We found delayed 
recovery of blood counts in Stra13 KO mice by day 7 when compared to WT 
control and hence this time point was chosen to analyze the BM compartment. 
Changes in HSC quiescence correlate to reciprocal changes in chemoresistance 
and radioresistance. Interestingly, we found that the lack of Stra13 in HSCs 
sensitizes them to genotoxic stress. There was a drastic reduction of LSK 
progenitors in Stra13 KO mice both by radiation and 5FU treatment in 







Figure 3.7: Stra13 KO LSK fraction is sensitive to genotoxic stress. 
Stra13 WT and KO mice were subjected to genotoxic stress in the form of sub lethal 
whole body gamma irradiation (5Gy) and after 24 hours were analyzed for the LSK 
population gated on Lin- population (middle panel). The myelotoxic drug 5FU 
(150mg/kg) was injected and LSK population analyzed after one week by flow 
cytometric analysis (right panel). In both cases, Stra13 WT and KO mice served as 
controls without any genotoxic treatment (left panel). Representative plots of n=3 mice 
analyzed. 
 
3.8 Gene expression profiling highlights genes potentially involved in 
hematopoietic stem cell ageing in Stra13 KO mice. 
Knowing that the aged Stra13 KO mice show reduced percentages of LSK and 
SLAM+ cells, we were interested to identify Stra13 target genes that could 
account for the reduced HSC numbers in Stra13 KO mice. We performed gene 
expression profiling using microarray on LSK cells isolated from ageing Stra13 
89 
 
KO and ageing littermate WT controls (12-13 months) [that did not develop the 
autoimmune phenotype]. Sorted LSK cells from young WT and Stra13 KO mice 
(2-3 months) were also hybridized and served as controls to identify the genes 
responsible for ageing phenotype. From these cells, total RNA was isolated, 
reverse transcribed, labeled and subsequently hybridized to Illumina mouse WG-6 
v2.0 array. The microarray identified 133 genes that were differentially expressed 
between ageing Stra13 KO and WT control. The top 6 genes that were 




Table II: Top genes differentially regulated in ageing Stra13 KO LSK vs WT 
LSK cells 
Gene 
Symbol Gene Name P <0.05 
Upregulated genes in Stra13 KO LSK (old) vs Stra13 WT LSK (old) 
Igl-V1 immunoglobulin lambda variable 1 0.02 
Tctn3 tectonic family member 3 0.03 
Tpst1 protein-tyrosine sulfotransferase 1 0.003 
Nedd4l 
neural precursor cell expressed, developmentally 
down-regulated gene 4-like 
0.02 
Bcorl1 BCL6 co-repressor-like 1 0.03 
Tstd2 
thiosulfate sulfurtransferase (rhodanese)-like 
domain containing 2 
0.03 
 
Downregulated genes in Stra13 KO LSK (old) vs Stra13 WT LSK (old) 
Ywhab 
tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, beta 
0.04 
Stx12 syntaxin 12 0.01 
Trib3 tribbles pseudokinase 3 0.02 
Fam168b family with sequence similarity 168, member B 0.001 
Tgm2 transglutaminase 2, C polypeptide 0.03 




Using DAVID functional analysis tool (Version 6.7), the biological significance 
of the differentially expressed genes list was better realised by classifying them 
based on Gene Ontology and with relevance to biological processes, molecular 
functions and pathways (Figure 3.8a). The top biological processes were cellular 
macromolecule metabolic process, cellular nitrogen metabolic process, gene 
expression, protein transport and localization, positive and negative regulation of 
cell proliferation, cell cycle checkpoints etc. Unbiased clustering between all the 
samples from young and ageing WT young and ageing Stra13 KO LSKs revealed 
four distinct clusters. Cellular metabolic process was the top biological process 
that was common in all the three clusters except in cluster 2.  In cluster 1, the top 
genes that were upregulated were Igl-v1, Nedd4l, Tctn3, Bcorl1, Tpst1. 
Interestingly; these same genes were significantly upregulated in ageing Stra13 vs 
ageing WT LSK and may be directly or indirectly involved in ageing Stra13 HSC 
phenotype.  





Figure 3.8: Heat Map, biological processes and pathway analysis of the 
differentially expressed genes in ageing Stra13 KO LSK vs WT LSK cells. 
a. Biological processes and functions altered between old Stra13 KO LSK vs. 
aged WT littermate control cells. Using DAVID annotation tool based on gene 
ontology, the top biological processes and functions were analyzed and 
schematically represented. 
b. A heat map showing the hierarchical unsupervised clustering of significantly 
deregulated genes. 4 patterns of concentrated deregulation were picked out using 
Partek Genomics Suite and plotted along with their associated molecular and 
cellular functions using DAVID analysis tool. Number of genes involved in the 
differential regulation of molecular and cellular functions is highlighted within 
brackets and the appropriate functions mentioned in each cluster is based on the 








3.9 Gene expression profiling reveals genes potentially involved in stress 
hematopoiesis in Stra13 KO mice 
 
Our previous results have highlighted that the Stra13 KO LSK compartment is 
sensitive to genotoxic stress i.e. sub lethal doses of gamma radiation. In order to 
elucidate the potential target genes that could be involved in this phenotype we 
took a similar approach of gene expression profiling. We performed gene 
expression profiling using microarray on LSK cells that were sorted after 24hrs 
from young Stra13 KO mice and their WT littermate subjected to sub lethal dose 
of whole body gamma radiation (5Gy). Sorted LSK cells from young WT and 
Stra13 KO mice (2-3 months) without radiation exposure were also hybridized 
and served as controls. From these cells, total RNA was isolated, reverse 
transcribed, labeled and subsequently hybridized to Illumina mouse WG-6 v2.0 
array. The data were imported into Partek Genomics Suite using RMA (Robust 
Multi-Chip Average) normalization. Differential expression and its statistical 
significance were calculated using linear contrasts with an ANOVA (analysis of 
variance) model. We identified 80 differentially expressed genes that were 
deregulated between Stra13 KO LSK and WT LSK upon radiation treatment. The 
top genes that were upregulated and downregualted in Stra13 KO LSK vs ageing 
WT LSK were as follows: 
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Table III: Top genes differentially regulated in Stra13 KO vs WT LSK cells 
upon sub lethal radiation treatment (5Gy) 
Gene 
Symbol Gene Name P<0.05 
Upregulated genes in Stra13 KO LSK (5Gy) vs Stra13 WT LSK (5Gy) 
Zfyve21 zinc finger, FYVE domain containing 21 
 
0.04 




Slc25a19 solute carrier family 25 (mitochondrial thiamine 
pyrophosphate carrier), member 19 
 
0.01 
Rdh11 retinol dehydrogenase 11 
 
0.02 
Ralgps2c Ral GEF with PH domain and SH3 binding motif 2 
 
0.01 
Sapcd2 Sapcd2 suppressor APC domain containing 2 
 
0.03 
Cd59a CD59a antigen 
 
0.02 
Car12 carbonic anyhydrase 12 
 
0.01 
Narfl nuclear prelamin A recognition factor-like 
 
0.03 
Pfkfb4 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 0.03 
 
F10 coagulation factor X 
 
0.04 
Srgap2 SLIT-ROBO Rho GTPase activating protein 2 0.02 
 
Downregulated genes in Stra13 KO LSK (5Gy) vs Stra13 WT LSK (5Gy) 














Pdgfb platelet derived growth factor, B polypeptide 
0.03 
 
Srxn1 sulfiredoxin 1 homolog 0.02 
Zdhhc19 
 













Using DAVID functional analysis tool (Version 6.7), the differentially expressed 
genes were annotated based on gene ontology. The top biological processes and 
pathways relevant to these genes were regulation of cell division, regulation of 
signal transduction, platelet derived growth factor (PDGF) signaling pathway, and 
actin cytoskeleton reorganization. For a clear understanding of other pathways 
important in LSK in response to radiation, we grouped the differentially expressed 
genes and unbiased clustering between all the samples revealed two distinct 
cluster using DAVID annotation tool (Figure 3.9). In cluster 1, the genes that 
were upregulated were Ifit-3, Zfyve21, Slc25a19, CD59 were similar to genes 
upregulated in Stra13 KO LSK (5Gy). Cluster 2 generally showed 
downregulation of many genes similar in Stra13 KO LSK (5Gy) like Jarid1a, 
Upf1, Pdgfb, Tmed7 which may play a role in the sensitivity of the LSK cells in 




Figure 3.9: Heat Map, biological processes and pathway analysis of the 
differentially expressed genes in Stra13 KO LSK vs WT LSK cells upon sub 
lethal gamma radiation. 
Unsupervised clustering of significantly deregulated genes in LSK cells treated with 
radiation between Stra13 KO LSK and WT LSK. 2 patterns of concentrated deregulation 
were picked out using Partek Genomics Suite and plotted along with their associated 
molecular and cellular functions using DAVID analysis tool. Number of genes involved 
in the differential regulation of molecular and cellular functions is highlighted within 
brackets and the appropriate functions mentioned in each cluster is based on the 





















                      4. DISCUSSION 
 
The hematopoietic system serves as a paradigm to understand the biology of 
hematopoietic stem cells (HSCs) and the processes involved in HSC ageing and 
disease. It is arguably the best characterized system among all other tissues of the 
human body due to its unique biological properties allowing easy experimental 
manipulation for pre-clinical studies. Transcriptional regulation of hematopoiesis 
has been studied in many organisms, which govern whether HSCs will self-renew 
or differentiate towards the myeloid, lymphoid or erythro-megakaryocytic 
lineages. However, the critical signals and transcription factors that control HSC 
fate are still not clearly defined. Over the years it has become evident that 
disruption of HSC homeostasis brings about qualitative and quantitative changes 
that affect the ability of HSCs to self renew and maintain normal blood levels and 
functions that eventually affect the ageing process and longevity of organisms. 
The main goal of my dissertation was to study the role of Stra13 in adult 
hematopoiesis as there have been no reports on its role in the hematopoietic 
compartment. Following a classical reverse genetic approach, we have 
demonstrated that Stra13 is highly expressed in LT-HSCs i.e. SLAM+ 
(CD150+CD48-) cells and LSK progenitors and its expression is downregulated in 
differentiated progenitor subsets CMP, GMP and MEP which indicates that 
Stra13 expression maybe important for self renewal of HSCs during steady state 
hematopoiesis. However, over-expression of Stra13 in LSK cells in vitro did not 
promote the self-renewal of HSCs or affect the clonogenic potential of 
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hematopoietic progenitor populations by colony forming assays.  We employed 
Stra13 knockout mice to understand whether its loss had any effect on the 
hematopoietic compartment. In accordance to our previous report, there were no 
significant differences in the major hematopoietic compartments - myeloid and 
lymphoid lineages in the bone marrow, spleen and thymus of young  (2-3 months) 
of Stra13 KO mice (Sun et al., 2001). Stra13 KO bone marrow showed similar 
percentages of SLAM+, LSK and other progenitors CMP, GMP, MEP and CLP 
compared to their wild type littermate control. Likewise, in vivo competitive 
repopulation transplantation assay confirmed that Stra13 null bone marrow can 
reconstitute the recipient bone marrow similar to its wild type control at 4 and 8 
weeks respectively. Our results demonstrate that loss or gain of Stra13 does not 
alter the number, function and repopulating ability of hematopoietic stem and 
progenitor cells and therefore Stra13 is dispensable during steady state 
hematopoiesis. One possibility that may explain the lack of phenotype is 
functional redundancy with other related transcription factors. Stra13 is highly 
related to Sharp-1 and both proteins mutually regulate each other (Azmi et al., 
2003; Li et al., 2003). The loss of Stra13 function may be compensated by Sharp-
1. However, the role of Sharp1 in hematopoiesis has not been investigated and it 
would be interesting to study if loss of both Stra13 and Sharp1 affect steady state 
hematopoiesis using Stra13-Sharp1 double knockout mice. Nonetheless, it is 
possible that other more distantly related bHLH-O transcription factors like Hes1, 
Hes5 and Hey 2 whose role in hematopoiesis have already been established may 
show some degree of functional redundancy with Stra13 in HSCs or compensate 
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for the loss of Stra13 function (Guiu et al., 2013; Rowlinson and Gering, 2010; 
Yu et al., 2006b). This still remains to be explored.  
Stra13 expression is upregulated in the LSK progenitors in ageing mice compared 
to young mice. These studies suggest that Stra13 expression may be modulated to 
provide a protective mechanism counteracting HSC ageing in order to maintain a 
balanced HSC composition. With ageing, normal wild type mice show elevated 
numbers of LT-HSCs and myeloid bias (Dykstra et al., 2011; Muller-Sieburg et 
al., 2004). However, we observed decreased percentages of SLAM+ and LSK 
cells and skewed myeloid and lymphoid progenitor fractions in ageing Stra13 KO 
mice. The GMP percentages were significantly lower compared to WT littermate 
control. On the other hand, we did not detect any changes in the relative 
composition of the different mature lineages in peripheral blood, bone marrow, 
spleen and thymus. This is not surprising as it has been previously reported that in 
spite of clear changes in HSC composition, the blood lineage ratio is not 
significantly altered (Cho et al., 2008). There exists a homeostatic mechanism that 
can overcome the differentiation bias of HSCs. There was an increase in CD48+ 
population in Stra13 KO mice compared to WT control (Figure 3.6.2.a). Previous 
reports have demonstrated the upregulation of CD48 on enriched HSCs isolated 
from 5FU treated bone marrow (Venezia et al., 2004). CD48 was preferentially 
expressed by restricted colony forming progenitors but not HSCs or transiently 
reconstituting multipotent progenitors in young adult bone marrow and hence they 
were considered as non HSC-contaminating cells. (Kiel et al., 2005; Yilmaz et al., 
2006). Competitive repopulation assays in which CD48+ and CD48- cells from 
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old, reconstituted, or mobilized mice were transplanted into lethally radiated 
recipients confirmed that CD48- cells have the multilineage reconstitution 
potential when compared to CD48+ cells  which showed little or no HSC activity 
in fractions of bone marrow cells, reconstituted bone marrow cells and mobilized 
splenocytes (Yilmaz et al., 2006). Hence, the increase in CD48+ percentages in 
aged Stra13 KO mice is another indicator of the decreased self renewal potential 
of Stra13 KO mice where majority of LT-HSCs become committed to form 
multipotent progenitors when compared to WT control. It would be interesting to 
study if CD48+ cells in Stra13 KO mice are lymphoid primed multipotent (LMPP) 
progenitors. Since the CLP compartment of Stra13 KO mice has not changed in 
both young and aged mice when compared to WT littermates we can speculate 
that the LMMPs which are precursors of CLP that have lost GMP potential may 
retain the same lymphoid differentiation capacity between Stra13 KO and WT 
control although this was not explored in our study. Similarly whether 
competitive repopulation transplantation assays using ageing Stra13 KO mice will 
recapitulate decreased myeloid reconstitution (as seen in ageing Stra13 KO) in 
recipient mice compared to its ageing WT control will be an interesting to 
explore. Our Stra13 KO phenotype with respect to hematopoiesis is similar to 
SIRT3 KO and FoxO3 KO mice in which the loss of either gene does not have 
any impact on stem cell numbers during steady state hematopoiesis. However, 
upon ageing, these KO mice demonstrate reduced frequency of HSCs due to 
elevation of reactive oxygen species (ROS) production (Brown et al., 2013; 
Miyamoto et al., 2007; Yalcin et al., 2008). In order to elucidate the potential 
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genes that may play a role in HSC ageing in Stra13 KO mice, we employed 
micro-array analysis. Through gene expression profiling between aged Stra13 KO 
LSK and aged WT LSK, we have identified potential target genes that were 
significantly upregulated in Stra13 KO vs WT LSK fractions. Broadly, many 
biological processes and functions like acetylation, cell proliferation, cell cycle 
check points and cell death were deregulated in ageing Stra13 KO LSK. In 
particular cellular metabolic processes were highly deregulated based on DAVID 
gene ontology tool.  HSCs generally have a low metabolic activity that prevents 
them from damage by ROS. An increase in metabolic activity in aged Stra13 KO 
may possibly indicate build up of ROS. FoxO3 is considered as a critical regulator 
of oxidative stress in HSCs (Yalcin et al., 2008), but FoxO3 was not in our list of 
differentially expressed genes that were upregulated in ageing Stra13 KO LSK.  
However, some of the mitochondrial genes like Ddah1, Tgm2, Acadvl and Mat2b 
were significantly downregulated. These results may indicate a disruption of 
mitochondrial machinery and build up of ROS that may lead to oxidative stress in 
ageing Stra13 LSK although this was not examined in our study. 
Similarly, BCoRL1 a homolog of BCor complex, a known co repressor of BCl-6 
was upregulated in ageing Stra13 LSK. In a study published recently, deletion of 
BCorL1 in Runx1 KO (an important HSC transcription factor) Lin- cells enhances 
its replating capacity (Ross et al., 2012). Hence, we may predict that BCorL1 
upregulation in ageing Stra13 KO LSK may function by repressing cell 
proliferation and self renewal of HSCs. Another gene TCNT3 known for its 
regulation of the Shh pathway (one of the developmental pathways regulating 
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hematopoiesis) and implicated in apoptosis was also upregulated in Stra13 KO 
LSK though its role in hematopoiesis is not known (Thomas et al., 2012). 
The next objective of my thesis focused on the role of Stra13 in hematopoiesis 
during genotoxic stress. Stra13 has been reported to be induced upon genotoxic 
stress and regulates ionizing induced apoptosis (Thin et al., 2007). Our results 
clearly show that the hematopoietic compartment of Stra13 KO mice is sensitive 
to both forms of genotoxic stress- namely ionizing gamma radiation and 5-FU. On 
subjecting to sub lethal doses of whole body gamma radiation of 5Gy we 
observed that the LSK compartment of Stra13 KO mice were extremely sensitive 
when compared to WT control after 24 hrs. Likewise intravenous injection of 5-
FU in Stra13 KO mice showed sensitivity in the LSK compartment even after 7 
days post injection. The LSK progenitor percentages were still significantly lower 
and showed prolonged myelosuppression compared to their WT LSK controls. It 
is interesting to note that the phenotype in Stra13 KO mice upon sublethal gamma 
radiation is similar to Necdin KO mice (Asai et al., 2012). Necdin is p53 target 
gene that regulates response to genotoxic stress of HSCs (Asai et al., 2012). 
Similarly, there have been reports that Stra13 is a downstream target of p53 (Qian 
et al., 2008). We may predict that enhanced sensitivity of Stra13 null LSK cells 
after genotoxic stress may be p53 dependent. However, this remains to be 
investigated.  
Therefore, to identify Stra13 target genes that account for the enhanced 
radiosensitivity of Stra13 KO HSCs, we performed gene-expression profiling on 
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LSK cells isolated from Stra13 null mice and WT mice after a sub lethal dose of 
5Gy radiation. Several deregulated genes and signaling pathways were identified 
in Stra13 KO LSK cells some of which were related to actin cytoskeleton 
organization, DNA damage, cell to cell junction, metal ion binding and GTPase 
activator. UPF1, a gene involved in S-phase progression and genome stability was 
downregualted in Stra13 KO LSK which indicates that Stra13 LSK are more 
susceptible to DNA damage compared to WT LSK cells (Azzalin and Lingner, 
2006). Similarly Srgap2, a gene expressed in LT-HSCs was upregulated in Stra13 
KO LSK cells (Forsberg et al., 2005). It is interesting to know some of the 
differentially expressed transcripts in Stra13 KO LSK fit into pathways and 
protein complexes not previously recognized in HSCs, possibly providing 
evidence of new HSC regulatory factors. However, the function of these genes 
involved in these different pathways in response to irradiation in Stra13 KO HSC 
remains to be validated. To further corroborate the Stra13 KO hematopoietic 
stress phenotype, studies can performed to detect the DNA damage by the 
formation of γ-H2AX foci by flow cytometry and DNA damage response such as 
activation of p53 dependent cell cycle check points. 
The spleen is a major site of extramedullary hematopoiesis. Adult mouse and 
human spleen retain low percentages of HSCs. When the bone marrow cannot 
cope with the body’s demand in times of stress and disease, the spleen serves a 
backup to generate all the different lineages of the blood (Chadburn, 2000). 
During recovery of hematopoiesis after irradiation, and under conditions of stress-
induced erythropoiesis, erythrocyte differentiation was accelerated in spleen of 
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Dhh-deficient mice compared with WT (Lau et al., 2012). Extramedullary 
hematopoiesis was not studied in Stra13 KO during steady state, ageing or under 
different genotoxic stress conditions. As a start point, it would be important to 
know if Stra13 is expressed in the HSC compartment of spleen and whether its 
expression increases during ageing and stress in a similar fashion as observed in 
the BM (Figure 3.1.2). We can predict that the expression of Stra13 maybe 
modulated in the HSC compartment of spleen during stress conditions. Stra13 KO 
mice under genotoxic stress by radiation or treatment with 5FU may show 
reduced extramedullary hematopoiesis.  
The role of HSCs during infections is not clearly defined. Major reports have 
focused on the role of committed myeloid and lymphoid progenitors to replenish 
immune cells after infection. Inflammatory signaling molecules like interferons, 
toll like receptors and tumor necrosis factor-α (TNF-α) have recently been 
identified to play important roles in HSC response (Baldridge et al., 2011). Severe 
infection such as sepsis or lipopolysaccharides treatment leads to T cell apoptosis 
and CLPs proliferate to compensate for this loss to replenish the immune cells. 
This homeostatic response is termed as emergency granulopoiesis or emergency 
lymphopoiesis. Unpublished data from our lab have shown that Stra13 expression 
is induced in macrophages upon stimulation with LPS. However the effects of 
LPS in the percentages of HSCs and progenitor fractions in Stra13 KO mice have 
not been studied. It would be interesting to study the long term effects of LPS in 
Stra13 KO mice and its impact on HSC function under transplantation settings. 
Likewise, TNF-α has been known to inhibit colony formation of human BM and 
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inhibit the in vitro growth of CD34+ cells and their ability to reconstitute NOD-
SCID mice (Broxmeyer et al., 1986; Dybedal et al., 2001). TNF-α additionally 
inhibits the proliferation of murine HSCs (Jacobsen et al., 1994; Zhang et al., 
1995). However TNF-α also been demonstrated to promote HSC clonogenecity 
and increase the proportion of progenitors in vitro and prevent HSC apoptosis in 
vitro and in vivo. (Rezzoug et al., 2008). Our lab has previously shown that 
peritoneal macrophages in Stra13 mutants show reduced levels of TNF-α during 
muscle repair after injury as macrophages are involved in muscle regeneration 
and clearance of necrotic debris (unpublished data). The expression levels of 
TNF-α in HSC compartment of Stra13 KO mice has not been investigated and it 
would be important to explore how TNF-α expression and function is modulated 
in Stra13 KO mice during infections. Since Stra13 KO mice develop a 
lymphoproliferative autoimmune disorder resembling systemic lupus 
erythematosus (SLE), the functional changes resemble to those seen in 
chronically infected animals. There is massive expansion of the HSC 
compartment in the bone marrow and abnormal accumulation of HSC in the 
periphery in lupus mice. Most of the changes in HSCs are induced by 
proinflammatory cytokines in both lupus and infected mice. Unlike infected mice 
where the HSCs have a compromised regenerative potential, lupus mice show 
enhanced self renewal regenerative potential (Niu et al., 2013). Stra13 KO lupus 
mice show a greatly expanded HSC population in the BM (Appendix-Figure I)   
and it will be important to analyze the regenerative potential of these HSCs by 
competitive repopulation assays. 
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Previous reports have shown that Stra13 physically interacts with Runx1 in Treg 
cells to synergistically regulate the expression of its target genes (Miyazaki et al., 
2010).  Runx1 and Stra13 are both induced by oncogenic Ras and the expression 
of Runx1 is upregulated in aged HSC fraction similar to Stra13 (Chambers et al., 
2007; Motoda et al., 2007). We therefore speculate that common target genes 
could be possibly regulated both by Stra13 and Runx1 during ageing of HSCs. 
Double knockouts of Stra13 and Runx1 mice could provide valuable insights 
about the combined role of these factors in ageing of HSCs.  
Collectively, our data clearly illustrates Stra13 as a novel gene in hematopoiesis 
which is dispensable during normal steady state hematopoiesis in adult mouse 

















                            5. CONCLUSION AND  
             FUTURE IMPLICATIONS 
 
Our work has demonstrated for the first time, the role of Stra13 in hematopoiesis. 
Our detailed study and analysis provides first evidence that Stra13 is expressed in 
the long term hematopoietic stem cells (LT-HSCs) and its associated progenitors. 
Using Stra13 knockout mice, we have uncovered its function in hematopoiesis. 
Our data strongly suggests that Stra13 is dispensable for adult murine 
hematopoiesis during steady state both in vitro and in vivo. However, the 
importance of Stra13 is realized during ageing and stress responses of HSCs 
where loss of Stra13 leads to reduced hematopoietic stem cell numbers in ageing 
mice and sensitivity to both forms of genotoxic stress- radiation and 
chemotherapy. In order to understand the broader role of Stra13 in regulating 
HSC renewal and numbers during ageing and stress, gene expression profiling 
revealed a wide array of genes that were deregulated in the absence of Stra13. 
Some of the genes identified may be direct or indirect targets of Stra13 and are 
genes previously not known to be involved during ageing or stress hematopoiesis. 
Future studies should be aimed at dissecting the roles of these genes in HSC self 
renewal to provide a better insight how hematopoietic stem cell signaling is 
regulated during ageing and stress or during steady state hematopoiesis. Since 
Stra13 has been reported to be a target of p53 gene, it will be interesting to 
explore if Stra13 like p53 is involved in the quiescence of HSCs (Liu et al., 2009; 
Qian et al., 2008). Stra13 gene is expressed in the suprachiasmatic nucleus (SCN) 
in a circadian fashion and is a regulator of mammalian clock genes along with 
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members such as Bmal1, Cry and Per genes (Grechez-Cassiau et al., 2004; 
Honma et al., 2002; Noshiro et al., 2004). Many reports have confirmed that HSC 
release, mobilization and trafficking are rhythmically controlled  (Giudice et al., 
2010; Lucas et al., 2008; Mendez-Ferrer et al., 2009; Mendez-Ferrer et al., 2008; 
Singh et al., 2011; Tsinkalovsky et al., 2006; Tsinkalovsky et al., 2007). The 
clock genes mPer1, mPer2, mBmal1 and mClock are active in mouse HSCs 
(Tsinkalovsky et al., 2005) and it would be interesting to examine the expression 
pattern of Stra13 in HSCs in mice subjected to different cycles of light and how 
the rhythmic pattern of HSC is modulated in Stra13 KO mice. Knowing that 
Stra13 is overexpressed in many solid tumors, it would not be surprising to 
establish a role for it in leukemia. There have been reports of Stra13 being highly 
expressed in leukemic cell lines (Ivanova et al., 2001). Preliminary studies from 
our lab (unpublished data) have indicated that Stra13 is overexpressed in a subset 
of acute myeloid leukemia patients including those with EVI1 overexpression and 
CBF-β-MYH11 (inv16) rearrangements. These results may suggest that Stra13 
may be also involved in leukemogenesis. Hence, targeting Stra13 may provide a 












     APPENDIX 
 
 I. Increased HSCs in Stra13 autoimmune lupus mice. 
The pioneer study on Stra13 knockout mice published from our lab has already 
demonstrated that by 6-8 months 90% of females and 50% of males develop an 
autoimmune phenotype similar to systemic lupus like disease. Hyper activated T 
and B cells infiltrate the systemic organs causing severe organ hyperplasia (Sun et 
al., 2001). A similar study corroborates this autoimmune phenotype although the 
manifestation of this disease was observed between 12-14 months (Miyazaki et 
al., 2010). The difference in onset of this lymphoproliferative disease could be 
due to the different genetic backgrounds used, the former being in a mixed 
background whereas the latter in C57BL/6 background. In this present study, our 
Stra13 KO mice have been derived in a pure C57BL/6 background and only about 
25-30% of Stra13 KO mice develop the autoimmune disease with ageing by 14-
16 months. Hence, we were interested to understand the effect of the lupus like 
condition in the hematopoietic compartment. To our surprise, we observed a 
massive expansion of the LSK and SLAM+ cell compartments in Stra13 lupus 
mice (Figure I a&b). This increase in HSCs percentages might be the effect of pro 
inflammatory cytokines that come into function in lupus mice and hence may play 
a major role in the upregulation of genes involved in the self renewal of HSCs. 
Hence, the increase in HSC pool size in Stra13 autoimmune KO mice is an 







Figure I: Increased HSC pool in Stra13 lupus mice. 
a. Ageing Stra13 KO mice 13-16 months that developed the autoimmune 





cytometry. LSK and LK cells are gated on Lin- population.  WT littermate ageing 
mice served as control. 
b. SLAM+ fraction of Stra13 KO lupus mice stained with antibodies positive for 
CD150 and negative for CD48 were gated on LSK fraction.  WT littermate ageing 
mice served as control. Representative images of (n=2) mice analyzed. 
 
 
II Retrovirus titre determination in NIH 3T3 cells 
 
To determine the titre of the concentrated retrovirus supernatants of pMIG and 
pMIG-Stra13 that was produced as described in section 2.6 we plated 1 x 105 
NIH3T3 cell in 6 well plates and the retroviral supernatants were added in the 
dilutions of 1:2, 1:5, 1:25, 1:125 to the culture medium after 24 hrs. NIH3T3 cells 
were incubated with the retroviral supernatants for 48 hours in the presence of 
protamine sulphate (8ug/ml) to increase infection efficiency, after which they 
were trypsinised and checked for the production of GFP+ cells by flow cytometry. 
The retrovirus titre was calculated according to the following formula: 
 
Titre (TU/ml) =              (%GFP positive cells/100) x # cells transduced)  













Figure II: Determination of retrovirus titre in NIH 3T3 cells by flow 
cytometry. 
a. Percentage of GFP+ cells with different dilutions of the pMIG retrovirus. Live 
cells gated and 20,000 events acquired for each dilution. 
b. Percentages of GFP+ cells with different dilutions of pMIG-Stra13 retrovirus 





III Stra13 mice genotyping and agarose gel electrophoresis  
Stra13 Primers: 
Primer 1 (350rv)  5’-CGTTTTATTCCCCGCCTGGA-3’ 
Primer-2 (STRA13-2RV)  5’-GGAAGCTCAGGCTAGCTCAT-3’ 
Primer-3 (STRA13-NEO1) 5’-TCGATTCCACCGCCGCCTTCTATG-3’  
 
Since the wild type and knockout allele PCR bands are approx around 380-400bp, 
the above PCR is carried out separately for detection of individual bands. 
For detection of Wild Type Allele/genotype 
Reagents X1 
10X Standard Taq Buffer 2.5ul 
10mM dNTPs 0.5ul 
Primer 1 (10uM) 1ul 
Primer 2  (10uM) 1ul 
25mM MgCl2 1.5ul 
Taq Polymerase 0.2 
Water 17.3 
Genomic DNA (200ng-300ng) 1ul 
Total 25ul 
 
For detection of Knockout Allele/genotype 
Reagents X1 
10X Standard Taq Buffer 2.5ul 
10mM dNTPs 0.5ul 
Primer 1 (10uM) 1ul 
Primer 3 (10uM) 1ul 
25mM MgCl2 1.5ul 
Taq Polymerase 0.2 
Water 17.3 
Genomic DNA (200ng-300ng) 1ul 
Total 25ul 
PCR conditions 
94 deg -5 minutes 
94 deg- 30 sec 
58 deg- 45 sec  Total 29 cycles 
72 deg -1 min   
72 deg- 5 min 
4deg - ∞ 
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Both the PCR samples are run simultaneously/in parallel on a 1.5% agarose gel as 
depicted in figure III. 
 
 
                                                         
                                                         
 
Figure III. Stra13 Genotyping on 1.5% agarose gel electrophoresis 
Abbreviation: WT- Wild type; HT- Heterozygous; KO- Knockout 
A single band in Primer 1 and Primer 2 indicates wild type genotype. A single 
band in Primer 1 and Primer 3 indicates knockout genotype. Bands in both 
(Primer 1 & Primer 2) & (Primer 1 & Primer 3) indicates heterozygous genotype. 
Primer 1 and Primer 2 
Primer 1 and Primer 3 
 
  WT    WT    KO     HT   WT   WT    WT    KO 
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Table IV: List of highly differentially expressed genes that were upregulated 
or downregulated in ageing Stra13 KO LSK vs. ageing WT LSK cells. 
Gene Symbol 
Gene Name P value 
<0.05 
                               Downregulated Genes 
Ddah1 dimethylarginine dimethylaminohydrolase 1 0.01 
Tgm2 transglutaminase 2, C polypeptide 0.03 
Fam168b family with sequence similarity 168, member B 0.001 
Trib3 tribbles pseudokinase 3 0.02 
Stx12 syntaxin 12 0.01 
Ywhab 
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein, beta 0.04 
Mylk myosin, light polypeptide kinase 0.02 
Bcat1 branched chain aminotransferase 1, cytosolic 0.01 
Ptpn14 protein tyrosine phosphatase, non-receptor type 14 0.02 
Luc7l Luc7 homolog (S. cerevisiae)-like 0.04 
Cd3eap CD3e molecule, epsilon associated protein 0.01 
Ahi1 Abelson helper integration site 1 0.007 
Wdr78 WD repeat domain 78   0.03 
Atg9b autophagy related 9B 0.04 
Wfdc2 WAP four-disulfide core domain 2 0.01 
Tle2 
transducin-like enhancer of split 2, homolog of Drosophila 
E(spl) 0.02 
Dhcr24 24-dehydrocholesterol reductase 0.02 
Pdxdc1 pyridoxal-dependent decarboxylase domain containing 1 0.04 
Mmrn1 multimerin 1 0.04 
Narfl nuclear prelamin A recognition factor-like 0.02 
Trim39 tripartite motif-containing 39 0.04 
116 
 
Creg1 cellular repressor of E1A-stimulated genes 1 0.01 
Zfp532 zinc finger protein 532 0.007 
Gabarapl1 
gamma-aminobutyric acid (GABA) A receptor-associated 
protein-like 1 0.02 
Zfp532 zinc finger protein 532 0.02 
Slc35b1 solute carrier family 35, member B1 0.04 
Trfr2 transferrin receptor 2 0.01 
Acadvl acyl-Coenzyme A dehydrogenase, very long chain 0.04 
Dusp4 dual specificity phosphatase 4 0.02 
Ift172 intraflagellar transport 172 0.001 
Sqle squalene epoxidase 0.01 
Zfp30 zinc finger protein 30 0.03 
Aplp2 amyloid beta (A4) precursor-like protein 2 0.03 
Frap1 mechanistic target of rapamycin 0.01 
Cryz crystallin, zeta 0.02 
Cish cytokine inducible SH2-containing protein 0.04 
Dlg3 discs, large homolog 3   0.03 
Slc16a9 
solute carrier family 16 (monocarboxylic acid transporters), 
member 9 0.04 
Ric8b resistance to inhibitors of cholinesterase 8 homolog B 0.002 
Grb7 growth factor receptor bound protein 7 0.04 
Otub2 OTU domain, ubiquitin aldehyde binding 2 0.03 
Tmem191c transmembrane protein 191C 0.02 
Mat2b methionine adenosyltransferase II, beta 0.02 
Gnptg N-acetylglucosamine-1-phosphotransferase, gamma subunit 0.02 
Evc2 Ellis van Creveld syndrome 2 0.003 
Dci/Eci enoyl-Coenzyme A delta isomerase 1 0.01 
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Kifap3 kinesin-associated protein 3 0.03 
Arnt aryl hydrocarbon receptor nuclear translocator 0.03 
Prr16 proline rich 16 0.03 
Prkcq protein kinase C, theta 0.04 
Capns1 calpain, small subunit 1 0.004 
Vti1a vesicle transport through interaction with t-SNAREs 1A 0.04 
Slc5a6 
olute carrier family 5 (sodium-dependent vitamin 
transporter), member 6 0.04 
Als2cr4 
amyotrophic lateral sclerosis 2 (juvenile) chromosome 
region, candidate 4 0.05 
Smarca2 
SWI/SNF related, matrix associated, actin dependent 
regulator of chromatin, subfamily a, member 2 0.03 
Ptprv protein tyrosine phosphatase, receptor type, V 0.04 
Rrp12 ribosomal RNA processing 12 homolog 0.02 
Hdgfl1 hepatoma derived growth factor-like 1 0.02 
Eefsec eukaryotic elongation factor, selenocysteine-tRNA-specific 0.04 
Zscan20 zinc finger and SCAN domains 20 0.008 
Rnf40 ring finger protein 40 0.04 
Ctxn1 cortexin 1 0.04 
Mrap melanocortin 2 receptor accessory protein 0.03 
Gm973 predicted gene 973 0.01 
Gm773 predicted gene 773 0.03 
Smndc1 survival motor neuron domain containing 1 0.04 
Chmp4c charged multivesicular body protein 4C 0.007 
Mic2l1/Cd99l2 CD99 antigen-like 2 0.04 
Ints5 integrator complex subunit 5 0.03 
4930565O14/ 
Gm16853 
predicted gene, 16853 0.03 
Ndufa8 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8 0.003 
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Snap23 synaptosomal-associated protein 23 0.03 
Rufy1 RUN and FYVE domain containing 1 0.01 
Rtn1 reticulon 1 0.04 
Mtx1 metaxin 1 0.02 
Krtap10-10 keratin associated protein 10-10 0.03 
Lrrc41 leucine rich repeat containing 41 0.006 
Slc30a7 solute carrier family 30 (zinc transporter), member 7 0.006 
Kbtbd4 kelch repeat and BTB (POZ) domain containing 4 0.03 
Fgf9 fibroblast growth factor 9 0.01 
Pcdhac2 protocadherin alpha subfamily C 0.04 
Rtp4 Rtp4 receptor transporter protein 4 0.004 
Tada3l transcriptional adaptor 3 0.02 
Aggf1 angiogenic factor with G patch and FHA domains 1 0.02 
Gm317/ 
Ccdc154 
Ccdc154 coiled-coil domain containing 154 0.04 
Smarcd2 
SWI/SNF related, matrix associated, actin dependent 
regulator of chromatin, subfamily d, member 2 0.02 
Aifm2 apoptosis-inducing factor, mitochondrion-associated 2 0.02 
Upregulated Genes 
Mycbpap MYCBP associated protein   0.04 
Yars2 tyrosyl-tRNA synthetase 2 0.01 
Pdhx pyruvate dehydrogenase complex, component X 0.005 
Ift20 intraflagellar transport 20 0.03 
Eef1a1 eukaryotic translation elongation factor 1 alpha 1 0.03 
Ing5 inhibitor of growth family, member 5 0.04 
Rps6 ribosomal protein S6 0.02 
Rpl27a ribosomal protein L27A 0.04 
Mfn2 mitofusin 2 0.02 
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Cul4b cullin 4B 0.01 
Mkrn3 makorin, ring finger protein, 3 0.01 
Rrm1 ribonucleotide reductase M1 0.04 
D12Ertd647e/ 
Ifi27 
interferon, alpha-inducible protein 27 0.03 
Irf2bp1 interferon regulatory factor 2 binding protein 1 0.04 
Fam114a2 family with sequence similarity 114, member A2 0.02 
Clspn claspin 0.02 
Pml promyelocytic leukemia 0.03 
Cstf3 cleavage stimulation factor, 3' pre-RNA, subunit 3 0.03 
Usp3 ubiquitin specific peptidase 3 0.03 
Srm spermidine synthase 0.03 
Tstd2 
thiosulfate sulfurtransferase (rhodanese)-like domain 
containing 2 0.03 
Bcorl1 BCL6 co-repressor-like 1 0.03 
Nedd4l 
neural precursor cell expressed, developmentally down-
regulated gene 4-like 0.02 
Tpst1 protein-tyrosine sulfotransferase 1 0.003 
Tctn3 tectonic family member 3 0.03 
 
Igl-V1 




Table V: List of highly differentially expressed genes that were upregulated 
or downregulated in Stra13 KO LSK vs. ageing WT LSK cells upon 5Gy 
gamma radiation.  
Gene Symbol 
Gene Name P<0.05 
                       Downregulated Genes 
Upf1 UPF1 regulator of nonsense transcripts homolog 0.02 
Tmed7 
transmembrane emp24 protein transport domain 
containing 7 
0.03 
Nrep neuronal regeneration related protein 0.03 
Zfp930 
 
zinc finger protein 930 0.04 
Srxn1 sulfiredoxin 1 homolog 0.02 
Pdgfb platelet derived growth factor, B polypeptide 0.03 
Olfr1203 olfactory receptor 1203 0.03 
Olfr281 olfactory receptor 281 0.02 
Gdpd5 
glycerophosphodiester phosphodiesterase domain 
containing 5 
0.02 
2900026A02Rik RIKEN cDNA 2900026A02 gene 0.02 
Zdhhc19 zinc finger, DHHC domain containing 19 0.04 
Tbc1d10a TBC1 domain family, member 10a 0.04 
LOC243025/ 
Tmem156 
transmembrane protein 156 0.03 
Rasal1 RAS protein activator like 1 (GAP1 like 0.02 
Tmub1 
transmembrane and ubiquitin-like domain 
containing 1 
0.04 
Doc2a double C2-like domains, alpha 0.03 
Wdr85 WD repeat domain 85 0.04 
Epb4.1l3 erythrocyte protein band 4.1-like 3 0.04 
Jarid1a jumonji, AT rich interactive domain 1A 0.04 




growth factor receptor bound protein 2-associated 
protein 2 
0.04 
Tsga8 testis specific gene A8 0.03 
Zfp563 zinc finger protein 563 0.04 
Polr3h 
polymerase (RNA) III (DNA directed) polypeptide 
H 
0.01 
Rnf123 ring finger protein 123 0.04 
5033413D22Rik/ 
Ccdc162 
coiled-coil domain containing 162 0.03 
Zfp532 zinc finger protein 532 0.02 
Sfmbt1 Scm-like with four mbt domains 1 0.04 
Ugt2b5 
UDP glucuronosyltransferase 2 family, polypeptide 
B5 
0.03 
Cat Catalase 0.008 
Evi5l ecotropic viral integration site 5 like 0.03 
Yars2 tyrosyl-tRNA synthetase 2 (mitochondrial 0.01 
Ano7 anoctamin 7 0.01 
Arhgap17 Rho GTPase activating protein 17 0.04 
Rnf41 ring finger protein 41 0.004 
Gucy1a3 guanylate cyclase 1, soluble, alpha 3 0.02 
Rab13 RAB13, member RAS oncogene family 0.04 
Zfp87 
 
zinc finger protein 87 0.04 




             Upregulated Genes 
Traf4 TNF receptor associated factor 4 0.03 
Ccdc50 coiled-coil domain containing 50 0.03 
Traf4 TNF receptor-associated factor 4 0.04 
Ccdc14 coiled-coil domain containing 14 0.01 
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Sdsl serine dehydratase-like 0.01 
Pign 
phosphatidylinositol glycan anchor biosynthesis, 
class N 
0.008 
Zfp715 zinc finger protein 715 0.008 
Fam118b family with sequence similarity 118, member B 0.02 
Rrbp1 ribosome binding protein 1 0.03 
Nanos1 nanos homolog 1 0.02 
Snx14 sorting nexin 14 0.04 
Sep6 septin 6 0.04 
Mt1 metallothionein 1 0.03 
Srgap2 SLIT-ROBO Rho GTPase activating protein 2 0.02 





Car12 carbonic anyhydrase 12 0.01 
Narfl nuclear prelamin A recognition factor-like 0.03 
Cd59a CD59a antigen 0.02 
2010317E24Rik/ 
Sapcd2 
suppressor APC domain containing 2 0.03 
2210408F11Rik RIKEN cDNA 2210408F11 gene 0.02 
Rdh11 retinol dehydrogenase 11 0.02 
Slc25a19 
solute carrier family 25 (mitochondrial thiamine 
pyrophosphate carrier), member 19 
0.01 
Ifit3 
interferon-induced protein with tetratricopeptide 
repeats 3 
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